QIK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A6NMY6 | T163 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| O00165 | S162 | Sugiyama | HAX1 HS1BP1 | GGVLESDARSEsPQPAPDWGsQRPFHRFDDVWPMDPHPRtR |
| O00231 | S298 | Sugiyama | PSMD11 | RYAGRQTEALKCVAQASKNRsLADFEKALTDYRAELRDDPI |
| O00410 | S239 | Sugiyama | IPO5 KPNB3 RANBP5 | PGFLQAVNDSCYQNDDSVLKsLVEIADTVPKYLRPHLEATL |
| O00468 | S738 | Sugiyama | AGRN AGRIN | CGSDGVTYSTECELKKARCEsQRGLYVAAQGACRGPTFAPL |
| O00571 | S71 | Sugiyama | DDX3X DBX DDX3 | GFyDKDSSGWsssKDKDAyssFGsRsDsRGKssFFsDRGsG |
| O00571 | S74 | Sugiyama | DDX3X DBX DDX3 | DKDSSGWsssKDKDAyssFGsRsDsRGKssFFsDRGsGsRG |
| O14639 | S452 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | PtPsAEGyQDVRDRMIHRstsQGsINsPVySRHsYtPTTSR |
| O14893 | S126 | Sugiyama | GEMIN2 SIP1 | QVAQFSTVRQNVNKHRSHWKsQQLDsNVTMPKSEDEEGWKK |
| O14910 | S135 | Sugiyama | LIN7A MALS1 VELI1 | DEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGDQL |
| O14974 | S445 | Sugiyama | PPP1R12A MBS MYPT1 | EEERKDEsPATWRLGLRKtGsyGALAEItASKEGQKEKDTA |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O15042 | S302 | Sugiyama | U2SURP KIAA0332 SR140 | NPQMNEEMLCQEFGRFGPLAsVKIMWPRTDEERARERNCGF |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15143 | S328 | Sugiyama | ARPC1B ARC41 | KAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCSQFCTT |
| O15226 | S618 | Sugiyama | NKRF ITBA4 NRF | VNKIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQ |
| O15523 | S71 | Sugiyama | DDX3Y DBY | GFHDKDSSGWSCSKDKDAyssFGsRDSRGKPGYFSERGSGS |
| O15523 | S74 | Sugiyama | DDX3Y DBY | DKDSSGWSCSKDKDAyssFGsRDSRGKPGYFSERGSGSRGR |
| O43290 | S378 | Sugiyama | SART1 | DGLRERELEEIRAKLRLQAQsLSTVGPRLASEYLtPEEMVT |
| O43707 | S763 | Sugiyama | ACTN4 | IARTINEVENQILtRDAKGIsQEQMQEFRASFNHFDKDHGG |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60291 | S515 | Sugiyama | MGRN1 KIAA0544 RNF156 | sFItEEVDESssPQQGTRAAsIENVLQDssPEHCGRGPPAD |
| O60343 | S588 | Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60664 | S175 | Sugiyama | PLIN3 M6PRBP1 TIP47 | RGAVQSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGK |
| O60664 | S179 | Sugiyama | PLIN3 M6PRBP1 TIP47 | QSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGKsEEW |
| O60664 | S217 | Sugiyama | PLIN3 M6PRBP1 TIP47 | EEWADNHLPLTDAELARIAtsLDGFDVAsVQQQRQEQSyFV |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | S230 | Sugiyama | CTNND1 KIAA0384 | PDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGyRA |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60749 | S119 | Sugiyama | SNX2 TRG9 | AVtPVtPttLIAPRIESKsMsAPVIFDRsREEIEEEANGDI |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75122 | S313 | Sugiyama | CLASP2 KIAA0627 | YNSLEPSYQKSLQTYLKssGsVAsLPQsDRsssssQEsLNR |
| O75122 | S327 | Sugiyama | CLASP2 KIAA0627 | YLKssGsVAsLPQsDRsssssQEsLNRPFSSKWSTANPSTV |
| O75347 | S60 | Sugiyama | TBCA | MRAEDGENyDIKKQAEILQEsRMMIPDCQRRLEAAyLDLQR |
| O75390 | S453 | Sugiyama | CS | LAQLIWSRALGFPLERPKSMsTEGLMKFVDSKSG_______ |
| O75390 | S97 | Sugiyama | CS | GLVyEtsVLDPDEGIRFRGFsIPECQKLLPKAKGGEEPLPE |
| O75534 | S584 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | YSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRP |
| O75581 | S1420 | PSP | LRP6 | PRMKGDGETMTNDYVVHGPAsVPLGYVPHPssLSGSLPGMS |
| O75581 | S1490 | SIGNOR|PSP | LRP6 | SSSSssTKGtYFPAILNPPPsPAtERsHYTMEFGYSsNsPs |
| O75822 | S127 | Sugiyama | EIF3J EIF3S1 PRO0391 | VLtPEEQLADKLRLKKLQEEsDLELAKEtFGVNNAVyGIDA |
| O75822 | S202 | Sugiyama | EIF3J EIF3S1 PRO0391 | VLVRDVCISLEIDDLKKITNsLTVLCsEKQKQEKQSKAKKK |
| O75828 | S69 | Sugiyama | CBR3 SDR21C2 | QLQAEGLsPRFHQLDIDDLQsIRALRDFLRKEYGGLNVLVN |
| O94776 | S54 | Sugiyama | MTA2 MTA1L1 PID | ANGNVEAKVVCLFRRRDIsssLNSLADSNAREFEEESKQPG |
| O94874 | S778 | Sugiyama | UFL1 KIAA0776 MAXER NLBP RCAD | DKEQEDVASTTRKELQELSssIKDLVLKSRKSsVTEE____ |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95218 | S75 | Sugiyama | ZRANB2 ZIS ZNF265 | tLAEKSRGLFsANDWQCKTCsNVNWARRsECNMCNtPKYAK |
| O95302 | S277 | Sugiyama | FKBP9 FKBP60 FKBP63 | KDSISIENKVVPENCERIsQsGDFLRYHYNGTLLDGTLFDS |
| O95347 | S315 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | ILRSLEDALAEAQRVNTKSQsAFDLKKKNLACEESKRKELE |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| P00338 | S105 | Sugiyama | LDHA PIG19 | VTANsKLVIItAGARQQEGEsRLNLVQRNVNIFKFIIPNVV |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S237 | Sugiyama | LDHA PIG19 | DLGtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVA |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P00568 | S38 | Sugiyama | AK1 | GSGKGTQCEKIVQKyGytHLstGDLLRSEVSSGSARGKKLs |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02545 | S295 | Sugiyama | LMNA LMN1 | RQsAERNsNLVGAAHEELQQsRIRIDsLsAQLsQLQKQLAA |
| P02786 | S137 | Sugiyama | TFRC | PAARRLyWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREA |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | S517 | Sugiyama | CAT | LDKYNAEKPKNAIHtFVQsGsHLAAREKANL__________ |
| P04075 | S17 | Sugiyama | ALDOA ALDA | ____MPyQyPALtPEQKKELsDIAHRIVAPGKGILAADEst |
| P04075 | S176 | Sugiyama | ALDOA ALDA | EHtPsALAIMENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S187 | Sugiyama | HSPB1 HSP27 HSP28 | APMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAAK__ |
| P04792 | S78 | Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T174 | Sugiyama | HSPB1 HSP27 HSP28 | SSsLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGP |
| P05023 | S369 | Sugiyama | ATP1A1 | KRMARKNCLVKNLEAVETLGstsTICSDKTGTLTQNRMTVA |
| P05187 | S192 | Sugiyama | ALPP PLAP | RVQHAsPAGtyAHtVNRNWysDADVPASARQEGCQDIATQL |
| P05198 | S219 | Sugiyama | EIF2S1 EIF2A | CYGYEGIDAVKEALRAGLNCsTENMPIKINLIAPPRYVMTT |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05388 | S37 | Sugiyama | RPLP0 | IIQLLDDyPKCFIVGADNVGsKQMQQIRMSLRGKAVVLMGK |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05783 | S312 | Sugiyama | KRT18 CYK18 PIG46 | AETTLTELRRtVQsLEIDLDsMRNLKAsLENsLREVEARYA |
| P05783 | S399 | Sugiyama | KRT18 CYK18 PIG46 | TYRRLLEDGEDFNLGDALDssNsMQtIQKtTTRRIVDGKVV |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P05787 | S477 | Sugiyama | KRT8 CYK8 | SSRAVVVKKIETRDGKLVsEssDVLPK______________ |
| P05787 | T413 | Sugiyama | KRT8 CYK8 | KLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGLtsP |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06744 | T109 | Sugiyama | GPI | KINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLDKM |
| P06748 | S243 | Sugiyama | NPM1 NPM | KGQEsFKKQEKtPKtPKGPssVEDIKAKMQAsIEKGGsLPK |
| P07195 | S106 | Sugiyama | LDHB | VtANSKIVVVtAGVRQQEGEsRLNLVQRNVNVFKFIIPQIV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | S439 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | NIVIAKMDstANEVEAVKVHsFPtLKFFPAsADRtVIDyNG |
| P07237 | T442 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | IAKMDstANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERt |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07339 | S42 | Sugiyama | CTSD CPSD | VRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQAVPAV |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | T163 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| P07384 | S474 | Sugiyama | CAPN1 CANPL1 PIG30 | GQPAVHLKRDFFLANAsRARsEQFINLREVSTRFRLPPGEY |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07711 | S329 | Sugiyama | CTSL CTSL1 | GGyVKMAKDRRNHCGIAsAAsyPtV________________ |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | S57 | Sugiyama | PFN1 | GKtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDs |
| P07737 | S58 | Sugiyama | PFN1 | KtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsL |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | S747 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | ETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVREL |
| P07814 | T737 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S164 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGT |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S468 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKENQ |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P08195 | S252 | Sugiyama | SLC3A2 MDU1 | AFQGHGAGNLAGLKGRLDyLssLKVKGLVLGPIHKNQKDDV |
| P08195 | S286 | Sugiyama | SLC3A2 MDU1 | KNQKDDVAQtDLLQIDPNFGsKEDFDsLLQsAKKKSIRVIL |
| P08238 | S159 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGT |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T94 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSGtKAFM |
| P08670 | S438 | Sugiyama | VIM | FssLNLREtNLDsLPLVDtHsKRTLLIKtVEtRDGQVINEt |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09651 | S360 | Sugiyama | HNRNPA1 HNRPA1 | PyGGGGQyFAKPRNQGGyGGssssssyGsGRRF________ |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09923 | S189 | Sugiyama | ALPI | RVQHAsPAGtyAHtVNRNWysDADMPASARQEGCQDIATQL |
| P09972 | S176 | Sugiyama | ALDOC ALDC | ERTPSALAILENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0DPB6 | S78 | Sugiyama | POLR1D | MIMKNPEVEFCGyTTTHPSEsKINLRIQTRGTLPAVEPFQR |
| P10696 | S189 | Sugiyama | ALPG ALPPL ALPPL2 | RVQHASPAGAYAHTVNRNWysDADVPASARQEGCQDIATQL |
| P10768 | S189 | Sugiyama | ESD | VSAFAPICNPVLCPWGKKAFsGyLGTDQsKWKAyDAtHLVK |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P11142 | S85 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | NtVFDAKRLIGRRFDDAVVQsDMKHWPFMVVNDAGRPKVQV |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11279 | S141 | Sugiyama | LAMP1 | NLSDTHLFPNASSKEIKtVEsITDIRADIDKKYRCVSGTQV |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P11586 | S318 | Sugiyama | MTHFD1 MTHFC MTHFD | FKPGKWMIQYNNLNLKTPVPsDIDIsRSCKPKPIGKLAREI |
| P11586 | S765 | Sugiyama | MTHFD1 MTHFC MTHFD | ARMFGIPVVVAVNAFKTDTEsELDLIsRLSREHGAFDAVKC |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12814 | S744 | Sugiyama | ACTN1 | IARTINEVENQILtRDAKGIsQEQMNEFRAsFNHFDRDHsG |
| P13010 | S318 | Sugiyama | XRCC5 G22P2 | NDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSEGK |
| P13473 | S155 | Sugiyama | LAMP2 | LTVDELLAIRIPLNDLFRCNsLSTLEKNDVVQHYWDVLVQA |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13489 | S225 | Sugiyama | RNH1 PRI RNH | KLEsCGVTSDNCRDLCGIVAsKASLRELALGSNKLGDVGMA |
| P13637 | S359 | Sugiyama | ATP1A3 | KRMARKNCLVKNLEAVETLGstsTICSDKTGTLTQNRMTVA |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13674 | S149 | Sugiyama | P4HA1 P4HA | GAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDCFE |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13797 | S540 | Sugiyama | PLS3 | NDDIIVNWVNRTLSEAGKSTsIQSFKDKTISSSLAVVDLID |
| P13798 | S187 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | EKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQFV |
| P13798 | S27 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | LsEPEEAAALyRGLSRQPALsAACLGPEVtTQyGGQyRTVH |
| P13798 | S303 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | YYVDLIGGKCELLSDDsLAVssPRLSPDQCRIVYLQYPSLI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S100 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | tHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGPEIR |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S447 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | PKyLNFVKGVVDsDDLPLNVsREtLQQHKLLKVIRKKLVRK |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P15880 | S249 | Sugiyama | RPS2 RPS4 | CtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEF |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P15924 | S2526 | Sugiyama | DSP | ITITGSDGSTRVVLVDRKtGsQyDIQDAIDKGLVDRKFFDQ |
| P16070 | S71 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLCKAFNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRI |
| P16152 | S69 | Sugiyama | CBR1 CBR CRN SDR21C1 | QLQAEGLsPRFHQLDIDDLQsIRALRDFLRKEYGGLDVLVN |
| P16949 | S46 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | PRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAEERRKsHEA |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17987 | S34 | Sugiyama | TCP1 CCT1 CCTA | GEtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTI |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18754 | S85 | Sugiyama | RCC1 CHC1 | IPEDVVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsV |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S356 | Sugiyama | NCL | LAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKVFGNEI |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20674 | S104 | Sugiyama | COX5A | PEPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYP |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P21108 | S10 | Sugiyama | PRPS1L1 PRPS3 PRPSL | ___________MPNIKIFsGssHQDLSQKIADRLGLELGKV |
| P21333 | S2152 | Sugiyama | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P21333 | S2158 | Sugiyama | FLNA FLN FLN1 | GRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQDMtAQV |
| P22059 | S190 | Sugiyama | OSBP OSBP1 | QRWVTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNT |
| P22059 | S382 | Sugiyama | OSBP OSBP1 | APEIITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLEETK |
| P22059 | S385 | Sugiyama | OSBP OSBP1 | IITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLEETKKEK |
| P22059 | S386 | Sugiyama | OSBP OSBP1 | ITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLEETKKEKR |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23284 | S150 | Sugiyama | PPIB CYPB | LKHyGPGWVsMANAGKDTNGsQFFITTVKTAWLDGKHVVFG |
| P23381 | S139 | Sugiyama | WARS1 IFI53 WARS WRS | RIERATGQRPHHFLRRGIFFsHRDMNQVLDAyENKKPFYLY |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P24534 | S174 | Sugiyama | EEF1B2 EEF1B EF1B | DMAKLEECVRsIQADGLVWGssKLVPVGyGIKKLQIQCVVE |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25054 | S2569 | Sugiyama | APC DP2.5 | REHSKHSSSLPRVSTWRRtGsSSSILSASSESSEKAKSEDE |
| P25054 | S960 | Sugiyama | APC DP2.5 | SENSNRTCSMPYAKLEYKRSsNDsLNSVSsSDGYGKRGQMK |
| P25205 | S277 | Sugiyama | MCM3 | RTVLIACNVKQMSKDAQPsFsAEDIAKIKKFSKTRsKDIFD |
| P25398 | S107 | Sugiyama | RPS12 | EWVGLCKIDREGKPRKVVGCsCVVVKDYGKESQAKDVIEEy |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25705 | S76 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | EERILGADtsVDLEETGRVLsIGDGIARVHGLRNVQAEEMV |
| P25789 | S7 | Sugiyama | PSMA4 HC9 PSC9 | ______________MSRRyDsRttIFsPEGRLYQVEYAMEA |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26232 | S667 | Sugiyama | CTNNA2 CAPR | YDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEEKAKIAEQV |
| P26373 | S106 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | IHKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLIL |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | T521 | Sugiyama | MAP4 | GLLKDMsPLsEtEMALGKDVtPPPEtEVVLIKNVCLPPEME |
| P27986 | S154 | SIGNOR|EPSD|PSP | PIK3R1 GRB1 | KLVEAIEKKGLECSTLyRtQssSNLAELRQLLDCDTPSVDL |
| P27986 | S541 | EPSD|PSP | PIK3R1 GRB1 | IQRIMHNyDKLKSRISEIIDsRRRLEEDLKKQAAEyREIDK |
| P28066 | S172 | Sugiyama | PSMA5 | QLFHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLK |
| P28066 | S174 | Sugiyama | PSMA5 | FHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEA |
| P28066 | S180 | Sugiyama | PSMA5 | GtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLI |
| P28838 | S180 | Sugiyama | LAP3 LAPEP PEPS | YEYDDLKQKKKMAVSAKLyGsGDQEAWQKGVLFAsGQNLAR |
| P28838 | S194 | Sugiyama | LAP3 LAPEP PEPS | SAKLyGsGDQEAWQKGVLFAsGQNLARQLMETPANEMTPtR |
| P29144 | S176 | Sugiyama | TPP2 | FDVANNGSsQANKLIKEELQsQVELLNsFEKKYSDPGPVYD |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29401 | S443 | Sugiyama | TKT | EDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAAN |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P30041 | S186 | Sugiyama | PRDX6 AOP2 KIAA0106 | SLQLTAEKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGV |
| P30048 | S199 | Sugiyama | PRDX3 AOP1 | SGLALRGLFIIDPNGVIKHLsVNDLPVGRSVEETLRLVKAF |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30622 | S195 | Sugiyama | CLIP1 CYLN1 RSN | AAKEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIG |
| P30622 | S197 | Sugiyama | CLIP1 CYLN1 RSN | KEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIGDR |
| P31153 | S247 | Sugiyama | MAT2A AMS2 MATA2 | IKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLtGRKII |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31327 | T900 | Sugiyama | CPS1 | KMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKC |
| P31943 | S23 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | LGTEGGEGFVVKVRGLPWsCsADEVQRFFSDCKIQNGAQGI |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | S16 | Sugiyama | STIP1 | _____MEQVNELKEKGNKALsVGNIDDALQCysEAIKLDPH |
| P31949 | S35 | Sugiyama | S100A11 MLN70 S100C | ESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKNQK |
| P34897 | S90 | Sugiyama | SHMT2 | GLELIAsENFCsRAALEALGsCLNNKYSEGYPGKRyyGGAE |
| P34932 | S363 | Sugiyama | HSPA4 APG2 HSPH2 | GATRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAIL |
| P34932 | S414 | Sugiyama | HSPA4 APG2 HSPH2 | ITDVVPYPISLRWNsPAEEGssDCEVFSKNHAAPFSKVLTF |
| P35221 | S668 | Sugiyama | CTNNA1 | FDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEQKAKIAEQV |
| P35237 | S306 | Sugiyama | SERPINB6 PI6 PTI | LRNLGMTDAFELGKADFSGMsQTDLSLSKVVHKSFVEVNEE |
| P35241 | S532 | Sugiyama | RDX | EERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHA |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35568 | S794 | GPS6|SIGNOR|iPTMNet|EPSD | IRS1 | tQRPGEPEEGARHQHLRLSTsSGRLLYAATADDSSSStSSD |
| P35606 | S350 | Sugiyama | COPB2 | MGDAEIKDGERLPLAVKDMGsCEIyPQtIQHNPNGRFVVVC |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S365 | Sugiyama | RPL4 RPL1 | RNHKLRVDKAAAAAAALQAKsDEKAAVAGKKPVVGKKGKKA |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | S83 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | CELINALYPEGQAPVKKIQAstMAFKQMEQIsQFLQAAERY |
| P38117 | T241 | Sugiyama | ETFB FP585 | KLSVIsVEDPPQRTAGVKVEtTEDLVAKLKEIGRI______ |
| P38646 | S549 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | IVHVSAKDKGTGREQQIVIQssGGLsKDDIENMVKNAEKYA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39748 | S255 | Sugiyama | FEN1 RAD2 | CESIRGIGPKRAVDLIQKHKsIEEIVRRLDPNKYPVPENWL |
| P40227 | S246 | Sugiyama | CCT6A CCT6 CCTZ | EDAyILTCNVSLEYEKTEVNsGFFyKSAEEREKLVKAERKF |
| P40818 | S718 | Sugiyama | USP8 KIAA0055 UBPY | AKPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtP |
| P41091 | S282 | Sugiyama | EIF2S3 EIF2G | FDVNKPGCEVDDLKGGVAGGsILKGVLKVGQEIEVRPGIVS |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S1098 | Sugiyama | MKI67 | PAARVTGMKKWPRtPKEEAQsLEDLAGFKELFQtPGPsEEs |
| P46013 | S651 | Sugiyama | MKI67 | ISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLGAKQ |
| P46060 | S454 | Sugiyama | RANGAP1 KIAA1835 SD | VstFLAFPsPEKLLRLGPKssVLIAQQTDTSDPEKVVSAFL |
| P46108 | S41 | Sugiyama | CRK | QEAVALLQGQRHGVFLVRDsstsPGDyVLSVSENSRVSHYI |
| P46459 | S298 | Sugiyama | NSF | NAREPKVVNGPEILNKyVGEsEANIRKLFADAEEEQRRLGA |
| P46459 | Y294 | Sugiyama | NSF | GKMLNAREPKVVNGPEILNKyVGEsEANIRKLFADAEEEQR |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P48637 | S276 | Sugiyama | GSS | VDGQEIAVVYFRDGYMPRQYsLQNWEARLLLERSHAAKCPD |
| P48643 | S154 | Sugiyama | CCT5 CCTE KIAA0098 | ADGYEQAARVAIEHLDKISDsVLVDIKDTEPLIQTAKTTLG |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P49005 | S75 | Sugiyama | POLD2 | ATRLIQMRPFLENRAQQHWGsGVGVKKLCELQPEEKCCVVG |
| P49321 | S659 | Sugiyama | NASP | IEELKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsst |
| P49321 | S662 | Sugiyama | NASP | LKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsstsGF |
| P49327 | S265 | Sugiyama | FASN FAS | TILNAGTNTDGFKEQGVtFPsGDIQEQLIRSLyQsAGVAPE |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49368 | S458 | Sugiyama | CCT3 CCTG TRIC5 | RAVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtW |
| P49588 | S627 | Sugiyama | AARS1 AARS | ATHILNFALRSVLGEADQKGsLVAPDRLRFDFTAKGAMSTQ |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P49589 | S307 | Sugiyama | CARS1 CARS | VPEAVGDQKALQEGEGDLsIsADRLsEKRSPNDFALWKASK |
| P49790 | S607 | Sugiyama | NUP153 | KtPPEDCEGPFRPAEILKEGsVLDILKsPGFAsPKIDSVAA |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49915 | S332 | Sugiyama | GMPS | IsDEDRtPRKRISKTLNMttsPEEKRKIIGDTFVKIANEVI |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50395 | T425 | Sugiyama | GDI2 RABGDIB | DAttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED |
| P50402 | T30 | Sugiyama | EMD EDMD STA | tELttLLRRyNIPHGPVVGstRRLyEKKIFEyEtQRRRLsP |
| P50454 | S138 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | LSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEH |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50454 | S141 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | STARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHSKI |
| P50990 | S380 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | VVVFKHEKEDGAIstIVLRGstDNLMDDIERAVDDGVNtFK |
| P50993 | S367 | Sugiyama | ATP1A2 KIAA0778 | KRMARKNCLVKNLEAVETLGstsTICSDKTGTLTQNRMTVA |
| P51116 | S504 | Sugiyama | FXR2 FMR1L2 | PTGGRGRGPPPAPRPTSRYNsSsISSVLKDPDsNPYSLLDt |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52594 | S359 | Sugiyama | AGFG1 HRB RAB RIP | AGQGGDQGSGFGTTGKAPVGsVVsVPsQssAssDKYAALAE |
| P52597 | S187 | Sugiyama | HNRNPF HNRPF | KALGKHKERIGHRYIEVFKssQEEVRsysDPPLKFMsVQRP |
| P52597 | S54 | Sugiyama | HNRNPF HNRPF | CtIHDGAAGVHFIYTREGRQsGEAFVELGsEDDVKMALKKD |
| P52597 | S63 | Sugiyama | HNRNPF HNRPF | VHFIYTREGRQsGEAFVELGsEDDVKMALKKDRESMGHRyI |
| P52907 | S123 | Sugiyama | CAPZA1 | KEAsDPQPEEADGGLKsWREsCDsALRAYVKDHYSNGFCTV |
| P52907 | S215 | Sugiyama | CAPZA1 | QVHYYEDGNVQLVSHKDVQDsLtVsNEAQtAKEFIKIIENA |
| P53041 | S403 | Sugiyama | PPP5C PPP5 | DLLWSDPQPQNGRSISKRGVsCQFGPDVTKAFLEENNLDyI |
| P53396 | S656 | Sugiyama | ACLY | IGNTGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISR |
| P53621 | S389 | Sugiyama | COPA | SYNPAENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPE |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54252 | S260 | Sugiyama | ATXN3 ATX3 MJD MJD1 SCA3 | IDMEDEEADLRRAIQLsMQGssRNIsQDMtQtsGTNLTSEE |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55072 | S282 | Sugiyama | VCP HEL-220 HEL-S-70 | TGAFFFLINGPEIMSKLAGEsEsNLRKAFEEAEKNAPAIIF |
| P55072 | S765 | Sugiyama | VCP HEL-220 HEL-S-70 | RsVsDNDIRKyEMFAQtLQQsRGFGsFRFPsGNQGGAGPsQ |
| P55196 | S216 | Sugiyama | AFDN AF6 MLLT4 | SRLAAEVYKDMPETSFTRtIsNPEVVMKRRRQQKLEKRMQE |
| P55735 | S184 | Sugiyama | SEC13 D3S1231E SEC13A SEC13L1 SEC13R | PGsLIDHPSGQKPNYIKRFAsGGCDNLIKLWKEEEDGQWKE |
| P55769 | S122 | Sugiyama | SNU13 NHP2L1 | CSVTIKEGSQLKQQIQsIQQsIERLLV______________ |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P55957 | S78 | Sugiyama | BID | QtDGNRssHsRLGRIEADsEsQEDIIRNIARHLAQVGDsMD |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P57721 | S82 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | GKKGETVKKMREESGARINIsEGNCPERIVTITGPTDAIFK |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S106 | Sugiyama | TPI1 TPI | DCGAtWVVLGHsERRHVFGEsDELIGQKVAHALAEGLGVIA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60520 | S39 | Sugiyama | GABARAPL2 FLC3A GEF2 | AKIRAKYPDRVPVIVEKVSGsQIVDIDKRKYLVPSDITVAQ |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60891 | S10 | Sugiyama | PRPS1 | ___________MPNIKIFsGssHQDLSQKIADRLGLELGKV |
| P60900 | S175 | Sugiyama | PSMA6 PROS27 | DPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTV |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61163 | S247 | Sugiyama | ACTR1A CTRN1 | NPQKDETLETEKAQyyLPDGstIEIGPSRFRAPELLFRPDL |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61326 | S106 | Sugiyama | MAGOH MAGOHA | QELEIVIGDEHISFTTSKIGsLIDVNQSKDPEGLRVFYYLV |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61769 | S108 | Sugiyama | B2M CDABP0092 HDCMA22P | TEFTPTEKDEYACRVNHVtLsQPKIVKWDRDM_________ |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S117 | Sugiyama | YWHAE | CCDILDVLDKHLIPAANtGEsKVFyyKMKGDYHRyLAEFAt |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62906 | S6 | Sugiyama | RPL10A NEDD6 | _______________MSSKVsRDtLyEAVREVLHGNQRKRR |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63165 | S61 | Sugiyama | SUMO1 SMT3C SMT3H3 UBL1 OK/SW-cl.43 | TTHLKKLKESYCQRQGVPMNsLRFLFEGQRIADNHtPKELG |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P78371 | S144 | Sugiyama | CCT2 99D8.1 CCTB | QTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIAG |
| P78371 | S150 | Sugiyama | CCT2 99D8.1 CCTB | WREATKAAREALLssAVDHGsDEVKFRQDLMNIAGTTLssK |
| P78371 | S470 | Sugiyama | CCT2 99D8.1 CCTB | IADNAGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAI |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q00610 | S1466 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | PLVKPYLRSVQNHNNKsVNEsLNNLFITEEDyQALRTsIDA |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q00688 | S34 | Sugiyama | FKBP3 FKBP25 | QLRSEQLPKKDIIKFLQEHGsDsFLAEHKLLGNIKNVAKTA |
| Q01081 | S19 | Sugiyama | U2AF1 U2AF35 U2AFBP FP793 | __MAEyLAsIFGtEKDKVNCsFYFKIGACRHGDRCsRLHNK |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01082 | S2048 | Sugiyama | SPTBN1 SPTB2 | VAEAWLLGQEPyLssREIGQsVDEVEKLIKRHEAFEKSAAT |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01581 | S404 | Sugiyama | HMGCS1 HMGCS | YSLKVTQDATPGSALDKITAsLCDLKSRLDSRTGVAPDVFA |
| Q02878 | S255 | Sugiyama | RPL6 TXREB1 | tEKEKYEITEQRKIDQKAVDsQILPKIKAIPQLQGYLRSVF |
| Q04637 | S1238 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RDAVKREAALPPVsPLKAALsEEELEKKsKAIIEEyLHLND |
| Q04726 | S622 | Sugiyama | TLE3 KIAA1547 | VWDLHNQTLVRQFQGHTDGAsCIDISHDGTKLWTGGLDNTV |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q06124 | S134 | Sugiyama | PTPN11 PTP2C SHPTP2 | HGHLSGKEAEKLLTEKGKHGsFLVREsQsHPGDFVLSVRTG |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07021 | S164 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | DGEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVL |
| Q07021 | S213 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | VGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDSLDW |
| Q07021 | T165 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVLD |
| Q08209 | S492 | Sugiyama | PPP3CA CALNA CNA | EAKGLDRINERMPPRRDAMPsDANLNsINKALTSETNGTDS |
| Q08378 | S1036 | Sugiyama | GOLGA3 | AKEAADAELGQLRAQGGSSDsSLALHERIQALEAELQAVSH |
| Q08378 | S500 | Sugiyama | GOLGA3 | LERAMTDLQNMLEAKNAsLAssNNDLQVAEEQyQRLMAKVE |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09666 | S220 | Sugiyama | AHNAK PM227 | QsGKtVIRLPsGsGAAsPtGsAVDIRAGAIsAsGPELQGAG |
| Q10471 | S536 | Sugiyama | GALNT2 | NDSRQKWEQIEGNSKLRHVGsNLCLDSRTAKSGGLSVEVCG |
| Q12888 | S1618 | Sugiyama | TP53BP1 | EQYGLGPYEAVtPLtKAADIsLDNLVEGKRKRRsNVssPAt |
| Q12931 | S361 | Sugiyama | TRAP1 HSP75 HSPC5 | SIFYVPDMKPSMFDVSRELGsSVALYSRKVLIQTKATDILP |
| Q13098 | S474 | Sugiyama | GPS1 COPS1 CSN1 | MLRAAVLRNQIHVKsPPREGsQGELtPANsQsRMstNM___ |
| Q13098 | S483 | Sugiyama | GPS1 COPS1 CSN1 | QIHVKsPPREGsQGELtPANsQsRMstNM____________ |
| Q13136 | S668 | Sugiyama | PPFIA1 LIP1 | EEKENTEQRAEEIESRVGsGsLDNLGRFRSMssIPPYPAss |
| Q13136 | T572 | Sugiyama | PPFIA1 LIP1 | LRRPQKGRLAALRDEPSKVQtLNEQDWERAQQASVLANVAQ |
| Q13243 | S153 | Sugiyama | SRSF5 HRS SFRS5 SRP40 | EVTFADAHRPKLNEGVVEFAsYGDLKNAIEKLSGKEINGRK |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | S253 | Sugiyama | G3BP1 G3BP | PAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPH |
| Q13283 | S362 | Sugiyama | G3BP1 G3BP | LFIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGF |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13347 | S217 | Sugiyama | EIF3I EIF3S2 TRIP1 | sRDMtMFVtASKDNTAKLFDsttLEHQKTFRTERPVNSAAL |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13573 | S182 | Sugiyama | SNW1 SKIIP SKIP | AMPVRAADKLAPAQyIRytPsQQGVAFNsGAKQRVIRMVEM |
| Q13586 | S512 | Sugiyama | STIM1 GOK | SPSLQSSVRQRLTEPQHGLGsQRDLtHsDsEssLHMSDRQR |
| Q13615 | S906 | Sugiyama | MTMR3 KIAA0371 ZFYVE10 | ETSLVERPQVGSVVHRTsLGstLsLTRsPCALPLAECKEGL |
| Q13625 | S480 | Sugiyama | TP53BP2 ASPP2 BBP | FDAVDQSNAPPSFGTLRKNQssEDILRDAQVANKNVAKVPP |
| Q13733 | S377 | Sugiyama | ATP1A4 ATP1AL2 | KRMARKNCLVKNLEAVETLGstsTICSDKTGTLTQNRMTVA |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14008 | S1873 | Sugiyama | CKAP5 KIAA0097 | LyEyKKKYsDADIEPFLKNSsQFFQSYVERGLRVIEMEREG |
| Q14103 | S271 | Sugiyama | HNRNPD AUF1 HNRPD | KCEIKVAMSKEQyQQQQQWGsRGGFAGRARGRGGGPSQNWN |
| Q14151 | S827 | Sugiyama | SAFB2 KIAA0138 | HGGPPERHGRDsRDGWGGyGsDKRLsEGRGLPPPPRGGRDW |
| Q14151 | Y825 | Sugiyama | SAFB2 KIAA0138 | HGHGGPPERHGRDsRDGWGGyGsDKRLsEGRGLPPPPRGGR |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S1258 | Sugiyama | EIF3A EIF3S10 KIAA0139 | RFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRERD |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14157 | S356 | Sugiyama | UBAP2L KIAA0144 NICE4 | HsMVsMLGKGFGDVGEAKGGsttGsQFLEQFKTAQALAQLA |
| Q14157 | S360 | Sugiyama | UBAP2L KIAA0144 NICE4 | sMLGKGFGDVGEAKGGsttGsQFLEQFKTAQALAQLAAQHS |
| Q14192 | S257 | Sugiyama | FHL2 DRAL SLIM3 | IsFEERQWHNDCFNCKKCsLsLVGRGFLTERDDILCPDCGK |
| Q14204 | S3257 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | NDKLKKMVKDQQEAEKKKVMsQEIQEQLHKQQEVIADKQMS |
| Q14204 | S4162 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GRIFVFEPPPGVKANMLRTFssIPVSRICKSPNERARLYFL |
| Q14432 | S273 | Sugiyama | PDE3A | RYVEQILPQSAEAAPREHLGsQLIAGTKEDIPVFKRRRRss |
| Q14432 | S312 | Sugiyama | PDE3A | sssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKRG |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14444 | S120 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | QEVtNNLEFAKELQRsFMALsQDIQKTIKKTARREQLMREE |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14568 | S164 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGT |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14677 | S163 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | DRLREERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSK |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14677 | S210 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | KNKSAFPFSDKLGELsDKIGstIDDtIsKFRRKDREDsPER |
| Q14980 | S1181 | Sugiyama | NUMA1 NMP22 NUMA | DsALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQD |
| Q14C86 | S902 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | AEMEAFKQRHSYPERLVRsRssDIVSSVRRPMSDPSWNRRP |
| Q14C86 | S903 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | EMEAFKQRHSYPERLVRsRssDIVSSVRRPMSDPSWNRRPG |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15021 | S1333 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | APsAKKPSTGSRyQPLAstAsDNDFVtPEPRRTTRRHPNTQ |
| Q15021 | T1331 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | QRAPsAKKPSTGSRyQPLAstAsDNDFVtPEPRRTTRRHPN |
| Q15029 | S948 | Sugiyama | EFTUD2 KIAA0031 SNRP116 | HLAREFMIKTRRRKGLsEDVsIsKFFDDPMLLELAKQDVVL |
| Q15029 | S950 | Sugiyama | EFTUD2 KIAA0031 SNRP116 | AREFMIKTRRRKGLsEDVsIsKFFDDPMLLELAKQDVVLNY |
| Q15078 | S91 | SIGNOR|EPSD|PSP | CDK5R1 CDK5R NCK5A | NSSYQNNITHLNNENLKKSLsCANLSTFAQPPPAQPPAPPA |
| Q15084 | S377 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | PAMAAINARKMKFALLKGsFsEQGINEFLRELsFGRGstAP |
| Q15121 | S116 | Sugiyama | PEA15 | DtKLtRIPsAKKYKDIIRQPsEEEIIKLAPPPKKA______ |
| Q15154 | S580 | Sugiyama | PCM1 | VNSHSNAQCVSNNRDGRTVNsNCEINNRsAANIRALNMPPS |
| Q15154 | S588 | Sugiyama | PCM1 | CVSNNRDGRTVNsNCEINNRsAANIRALNMPPSLDCRYNRE |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S82 | Sugiyama | PTGES3 P23 TEBP | NDsKHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVD |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q15276 | S407 | Sugiyama | RABEP1 RAB5EP RABPT5 RABPT5A | GDPFSKSDNDMFKDGLRRAQstDsLGtsGsLQSKALGYNYK |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q15365 | S50 | Sugiyama | PCBP1 | GKKGESVKRIREEsGARINIsEGNCPERIItLTGPTNAIFK |
| Q15366 | S50 | Sugiyama | PCBP2 | GKKGESVKKMREESGARINIsEGNCPERIITLAGPTNAIFK |
| Q15424 | S803 | Sugiyama | SAFB HAP HET SAFB1 | RHGGPERHGRDsRDGWGGyGsDKRMsEGRGLPPPPRRDWGD |
| Q15424 | Y801 | Sugiyama | SAFB HAP HET SAFB1 | PERHGGPERHGRDsRDGWGGyGsDKRMsEGRGLPPPPRRDW |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15746 | S343 | PSP | MYLK MLCK MLCK1 MYLK1 | ESCKDSPRTAPQtPVLQKTSsSITLQAARVQPEPRAPGLGV |
| Q15751 | S1512 | Sugiyama | HERC1 | LtAESRLVHtsPNYRLIKsRsEsDLsQPEsDEEGYALsGRR |
| Q15751 | S1514 | Sugiyama | HERC1 | AESRLVHtsPNYRLIKsRsEsDLsQPEsDEEGYALsGRRNV |
| Q15818 | S91 | Sugiyama | NPTX1 | TILSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQP |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16658 | S237 | Sugiyama | FSCN1 FAN1 HSN SNL | RsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALE |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16836 | S196 | Sugiyama | HADH HAD HAD1 HADHSC SCHAD | PVMKLVEVIKTPMTSQKTFEsLVDFSKALGKHPVSCKDTPG |
| Q2VIR3 | S282 | Sugiyama | EIF2S3B | FDVNKPGCEVDDLKGGVAGGsILKGVLKVGQETEVRPGIVS |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3V6T2 | S1702 | Sugiyama | CCDC88A APE GRDN KIAA1212 | TLQQFLEEsNKLTSVQIKsssQENLLDEVMKSLsVssDFLG |
| Q53EL6 | S46 | Sugiyama | PDCD4 H731 | GDEENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKN |
| Q53ET0 | S171 | GPS6|SIGNOR|iPTMNet|EPSD | CRTC2 TORC2 | NFPAEKGQLFRLPSALNRtssDsALHtsVMNPsPQDtYPGP |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5JSH3 | S565 | Sugiyama | WDR44 RPH11 | DYFNNMRMKYNtEGRVsPsPsQEsLsssKsDTDtGVCsGtD |
| Q5JVF3 | S24 | Sugiyama | PCID2 HT004 | ITINQYLQQVYEAIDSRDGAsCAELVSFKHPHVANPRLQMA |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5SSJ5 | S227 | Sugiyama | HP1BP3 | LKRELNRGVIKQVKGKGAsGsFVVVQKSRKTPQKSRNRKNR |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5VT25 | S222 | Sugiyama | CDC42BPA KIAA0451 | IKPDNILMDMNGHIRLADFGsCLKLMEDGTVQsSVAVGtPD |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6GYQ0 | S797 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EtGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDM |
| Q6NVY1 | S381 | Sugiyama | HIBCH | PADLKEVtEEDLNNHFKSLGsSDLKF_______________ |
| Q6P996 | S721 | Sugiyama | PDXDC1 KIAA0251 | LPGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQ |
| Q6PID6 | S19 | Sugiyama | TTC33 | __MASFGWKRKIGEKVSKVTsQQFEAEAADEKDVVDNDEGN |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6UUV9 | S151 | GPS6|EPSD | CRTC1 KIAA0616 MECT1 TORC1 WAMTP1 | CPYGTMYLsPPADTSWRRtNsDsALHQstMtPtQPEsFssG |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q7Z417 | S671 | Sugiyama | NUFIP2 KIAA1321 PIG1 | DsWGsFDLRAAIVYHTKEMEsIWNLQKQDPKRIItyNEAMD |
| Q7Z460 | S545 | Sugiyama | CLASP1 KIAA0622 MAST1 | yHTLESSyQKALQSHLKNSDsIVsLPQsDRsssssQEsLNR |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86VQ1 | S226 | Sugiyama | GLCCI1 | sCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQRSKQ |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IYB3 | T239 | Sugiyama | SRRM1 SRM160 | KtPELPEPsVKVKEPsVQEAtstsDILKVPKPEPIPEPKEP |
| Q8IZP0 | S22 | Sugiyama | ABI1 SSH3BP1 | AELQMLLEEEIPSGKRALIEsyQNLTRVADyCENNyIQATD |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8N806 | S265 | Sugiyama | UBR7 C14orf130 | KDDVREVKVEQNsEPCAGsssEsDLQtVFKNESLNAESKSG |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NHW5 | S37 | Sugiyama | RPLP0P6 | IIQLLDDyPKCFIVGADNVGsKQMQQIRMSLRGKVVVLMGK |
| Q8TDD1 | S581 | Sugiyama | DDX54 | RLVDSIKNYRSRATIFEINAsSRDLCsQVMRAKRQKDRKAI |
| Q8WU68 | S19 | Sugiyama | U2AF1L4 U2AF1-RS3 U2AF1L3 | __MAEyLAsIFGtEKDKVNCsFYFKIGVCRHGDRCSRLHNK |
| Q8WU90 | S351 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLsEAs |
| Q8WUF5 | S102 | Sugiyama | PPP1R13L IASPP NKIP1 PPP1R13BL RAI | RGsPRKAATDGADtPFGRsEsAPtLHPysPLsPKGRPssPR |
| Q8WWH5 | S268 | Sugiyama | TRUB1 PUS4 | ECGGGFYIRSLVSDIGKELSsCANVLELTRTKQGPFTLEEH |
| Q8WWI1 | S1510 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RsAsVNKEPVSLPGIMRRGEsLDNLDsPRSNSWRQPPWLNQ |
| Q8WWI1 | S704 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | KKRLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEM |
| Q8WXH0 | S2781 | Sugiyama | SYNE2 KIAA1011 NUA | ILSQIRKCKVTHDGILARQQsVEsLAEEVKDKVPSLTTYEG |
| Q92499 | S541 | Sugiyama | DDX1 | NLEQYFIQQGGGPDKKGHQFsCVCLHGDRKPHERKQNLERF |
| Q92526 | S246 | Sugiyama | CCT6B | EDAFILICNVSLEYEKTEVNsGFFyKTAEEKEKLVKAERKF |
| Q92609 | S541 | Sugiyama | TBC1D5 KIAA0210 | EsMPVQLNKGLSSKNIsssPsVEsLPGGREFtGsPPssAtK |
| Q92626 | S1300 | Sugiyama | PXDN KIAA0230 MG50 PRG2 PXD01 VPO VPO1 | NITRVQSDVFRVAEFPHGyGsCDEIPRVDLRVWQDCCEDCR |
| Q92974 | S711 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | sGGNtsPGVtANGEARTFNGsIELCRADsDssQRDRNGNQL |
| Q93045 | S80 | Sugiyama | STMN2 SCG10 SCGN10 | PPsPISEAPRTLAsPKKKDLsLEEIQKKLEAAEERRKsQEA |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96A72 | S108 | Sugiyama | MAGOHB MAGOH2 | QELEIVIGDEHISFTTSKIGsLIDVNQSKDPEGLRVFYYLV |
| Q96AC1 | S255 | Sugiyama | FERMT2 KIND2 MIG2 PLEKHC1 | KMFKPQALLDKAKINQGWLDsSRSLMEQDVKENEALLLRFK |
| Q96AE4 | S270 | Sugiyama | FUBP1 | MVLELIRDQGGFREVRNEyGsRIGGNEGIDVPIPRFAVGIV |
| Q96D15 | S98 | Sugiyama | RCN3 UNQ239/PRO272 | ARLGRIVDRMDRAGDGDGWVsLAELRAWIAHTQQRHIRDsV |
| Q96EP5 | S208 | Sugiyama | DAZAP1 | AEPRDsKsQAPGQPGAsQWGsRVVPNAANGWAGQPPPTWQQ |
| Q96ES7 | S31 | Sugiyama | SGF29 CCDC101 | AELLTELHQLIKQTQEERsRsEHNLVNIQKTHERMQTENKI |
| Q96EY7 | S651 | Sugiyama | PTCD3 MRPS39 TRG15 | VELASAFSLPICEGLTQRVMsDFAINQEQKEALsNLtALts |
| Q96HP0 | S190 | Sugiyama | DOCK6 KIAA1395 | NDSRRGsGsPEDtPRssGASsIFDLRNLAADSLLPSLLERA |
| Q96IR7 | S360 | Sugiyama | HPDL GLOXD1 | LIQRQGATGFGQGNIRALWQsVQEQsARSQEA_________ |
| Q96L92 | S51 | Sugiyama | SNX27 KIAA0488 My014 | AGNGGGGGGGPRVVRIVKsEsGYGFNVRGQVsEGGQLRSIN |
| Q96N67 | S1438 | Sugiyama | DOCK7 KIAA1771 | LGTYTIAsPPERsPsGsAFGsQENLRWRKDMTHWRQNTEKL |
| Q96PK6 | S520 | Sugiyama | RBM14 SIP | AAAAYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASY |
| Q96PK6 | S620 | Sugiyama | RBM14 SIP | KRYGSDRRLAELsDYRRLsEsQLsFRRsPtKSSLDYRRLPD |
| Q96S59 | S181 | Sugiyama | RANBP9 RANBPM | QEtPLPRSWsPKDKFsYIGLsQNNLRVHYKGHGKTPKDAAS |
| Q96S59 | S613 | Sugiyama | RANBP9 RANBPM | DCDtEMEVDSsQLRRQLCGGsQAAIERMIHFGRELQAMSEQ |
| Q99439 | S217 | Sugiyama | CNN2 | ILPPMDHSTISLQMGTNKCAsQVGMTAPGTRRHIyDTKLGT |
| Q99613 | S754 | Sugiyama | EIF3C EIF3S8 | REHVVAASKAMKMGDWKTCHsFIINEKMNGKVWDLFPEADK |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99627 | S157 | Sugiyama | COPS8 CSN8 | VGLPVEEAVKGILEQGWQADstTRMVLPRKPVAGALDVsFN |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BRG2 | S180 | Sugiyama | SH2D3A NSP1 UNQ175/PRO201 | EDPAGMEASTMPISALPRtssDPVLLKAPAPLGTVADsLRA |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9BT78 | S297 | Sugiyama | COPS4 CSN4 | QLQEFAAMLMPHQKATTADGssILDRAVIEHNLLSASKLYN |
| Q9BT78 | S340 | Sugiyama | COPS4 CSN4 | TFEELGALLEIPAAKAEKIAsQMITEGRMNGFIDQIDGIVH |
| Q9BV73 | S2392 | SIGNOR|EPSD|PSP | CEP250 CEP2 CNAP1 | DYITRSAQTSRELAGLHHsLsHsLLAVAQAPEATVLEAETR |
| Q9BV73 | S2394 | SIGNOR|EPSD|PSP | CEP250 CEP2 CNAP1 | ITRSAQTSRELAGLHHsLsHsLLAVAQAPEATVLEAETRRL |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BX40 | S165 | Sugiyama | LSM14B C20orf40 FAM61B RAP55B | GFPSIPVGKsPMVEQAVQtGsADNLNAKKLLPGKGTTGTQL |
| Q9BX40 | T163 | Sugiyama | LSM14B C20orf40 FAM61B RAP55B | GAGFPSIPVGKsPMVEQAVQtGsADNLNAKKLLPGKGTTGT |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZ72 | S644 | Sugiyama | PITPNM2 KIAA1457 NIR3 | SGGGGSSGGSSLESSRHLsRsNVDIPRSNGTEDPKRQLPRK |
| Q9C0C2 | S1229 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LESGGSEEPGGIGVGEKDWtsDVNVKSKDLAEVGEGGGHsQ |
| Q9C0C9 | S115 | Sugiyama | UBE2O KIAA1734 | GRGssGCSEAGGAGHEEGRAsPLRRGYVRVQWYPEGVKQHV |
| Q9H0H5 | S257 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | ETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPRTETDsVGt |
| Q9H0K1 | S342 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | SYNHFAAIYFLLVERLKSHRssFPVEQRLDGRQRRPstIAE |
| Q9H0K1 | S343 | SIGNOR|EPSD|PSP|Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | YNHFAAIYFLLVERLKSHRssFPVEQRLDGRQRRPstIAEQ |
| Q9H0K1 | S358 | EPSD|PSP|Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | KSHRssFPVEQRLDGRQRRPstIAEQtVAKAQtVGLPVTMH |
| Q9H0K1 | S379 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | tIAEQtVAKAQtVGLPVTMHsPNMRLLRSALLPQASNVEAF |
| Q9H0K1 | S486 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | PAHAFEAFQSTRSGQRRHtLsEVtNQLVVMPGAGKIFSMND |
| Q9H0K1 | S534 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | DSEYDMGSVQRDLNFLEDNPsLKDIMLANQPsPRMTSPFIS |
| Q9H0K1 | S545 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | DLNFLEDNPsLKDIMLANQPsPRMTSPFISLRPTNPAMQAL |
| Q9H0K1 | S576 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | RPTNPAMQALSSQKREVHNRsPVsFREGRRAsDtsLtQGIV |
| Q9H0K1 | S579 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | NPAMQALSSQKREVHNRsPVsFREGRRAsDtsLtQGIVAFR |
| Q9H0K1 | S587 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | SQKREVHNRsPVsFREGRRAsDtsLtQGIVAFRQHLQNLAR |
| Q9H0K1 | S590 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | REVHNRsPVsFREGRRAsDtsLtQGIVAFRQHLQNLARTKG |
| Q9H0K1 | S674 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | QQESVSTLPASVHPQLSPRQsLEtQYLQHRLQKPSLLSKAQ |
| Q9H0K1 | S707 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | PSLLSKAQNtCQLYCKEPPRsLEQQLQEHRLQQKRLFLQKQ |
| Q9H0K1 | S90 | EPSD|PSP | SIK2 KIAA0781 QIK SNF1LK2 | IMKMLDHPHIIKLYQVMETKsMLYLVTEYAKNGEIFDYLAN |
| Q9H0K1 | T359 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | SHRssFPVEQRLDGRQRRPstIAEQtVAKAQtVGLPVTMHs |
| Q9H0K1 | T364 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | FPVEQRLDGRQRRPstIAEQtVAKAQtVGLPVTMHsPNMRL |
| Q9H0K1 | T370 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | LDGRQRRPstIAEQtVAKAQtVGLPVTMHsPNMRLLRSALL |
| Q9H0K1 | T484 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | EDPAHAFEAFQSTRSGQRRHtLsEVtNQLVVMPGAGKIFSM |
| Q9H0K1 | T489 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | AFEAFQSTRSGQRRHtLsEVtNQLVVMPGAGKIFSMNDSPS |
| Q9H0K1 | T589 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | KREVHNRsPVsFREGRRAsDtsLtQGIVAFRQHLQNLARTK |
| Q9H0K1 | T592 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | VHNRsPVsFREGRRAsDtsLtQGIVAFRQHLQNLARTKGIL |
| Q9H0K1 | T677 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | SVSTLPASVHPQLSPRQsLEtQYLQHRLQKPSLLSKAQNtC |
| Q9H0K1 | T696 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | EtQYLQHRLQKPSLLSKAQNtCQLYCKEPPRsLEQQLQEHR |
| Q9H173 | S128 | Sugiyama | SIL1 UNQ545/PRO836 | DKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEMESsK |
| Q9H299 | S14 | Sugiyama | SH3BGRL3 P1725 | _______MSGLRVYSTSVTGsREIKSQQsEVTRILDGKRIQ |
| Q9H2G2 | S341 | Sugiyama | SLK KIAA0204 STK2 | EDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACILE |
| Q9H2J4 | S151 | Sugiyama | PDCL3 PhLP2A VIAF1 | NQHLSGLARKFPDVKFIKAIsTTCIPNYPDRNLPTIFVYLE |
| Q9H3N1 | S228 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | PSKRRRPQPYPYPSKKLLsEsAQPLKKVEEEQEADEEDVsE |
| Q9H501 | S77 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | GRPISHSTTEDLKRFyDLsDsDsNLsGEDSKALSQKKIKKK |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9H7E9 | T40 | Sugiyama | C8orf33 | PCAsRGARLPGPVsSARNPstVCLCPEQPTCSNADSRAHPL |
| Q9HA77 | T546 | Sugiyama | CARS2 OK/SW-cl.10 | CDTLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG__ |
| Q9HA77 | T547 | Sugiyama | CARS2 OK/SW-cl.10 | DTLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG___ |
| Q9HAP6 | S120 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | DEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGDQL |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9HCN8 | S40 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | ALLVPGGGAAKTGAELVTCGsVLKLLNTHHRVRLHSHDIKY |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NRY5 | S209 | Sugiyama | FAM114A2 C5orf3 | AEGDPGFKRTKGLMNRNATLsQVLREAKEKEEIRTSNEVTV |
| Q9NRZ9 | T166 | Sugiyama | HELLS PASG SMARCA6 Nbla10143 | EILSVAKKNKKENEDENssstNLCVEDLQKNKDSNSIIKDR |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NTX5 | S113 | Sugiyama | ECHDC1 | LENWTEGKGLIVRGAKNTFSsGSDLNAVKSLGTPEDGMAVC |
| Q9NUP9 | S120 | Sugiyama | LIN7C MALS3 VELI3 | EEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGDQL |
| Q9NWU1 | S108 | Sugiyama | OXSM | VAAYVPRGSDEGQFNEQNFVsKSDIKSMSSPTIMAIGAAEL |
| Q9NYB9 | S22 | Sugiyama | ABI2 ARGBPIA | AELQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSAD |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9P265 | S203 | Sugiyama | DIP2B KIAA1463 | stsssASSTLSHGEVKGtsGsLADVFANtRIENFSAPPDVT |
| Q9P2E9 | S896 | Sugiyama | RRBP1 KIAA1398 | SEEALQKRLDEVSRELCHTQsSHASLRADAEKAQEQQQQMA |
| Q9UBF8 | T426 | Sugiyama | PI4KB PIK4CB | CENFDTTSVPARIPENRIRstRsVENLPECGItHEQRAGSF |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UGU0 | S1187 | Sugiyama | TCF20 KIAA0292 SPBP | sDGLPNKGMELKHGSQKLQEsCWDLsRQTsPAKSSGPPGMS |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UJU6 | T270 | Sugiyama | DBNL CMAP SH3P7 PP5423 | EQESAVHPREIFKQKERAMsttsIssPQPGKLRsPFLQKQL |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UPQ0 | S1054 | Sugiyama | LIMCH1 KIAA1102 | YFHIQCFRCGICKGQLGDAVsGTDVRIRNGLLNCNDCyMRS |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQL6 | S259 | PSP | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S178 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NVKDKLCSKRtDLCDHALHIsHDEL________________ |
| Q9Y2B0 | S55 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDELEWEIAQVDPKKTIQMGsFRINPDGsQsVVEVPyARsE |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2L1 | S633 | Sugiyama | DIS3 KIAA1008 RRP44 | LNKLAKILKKRRIEKGALTLssPEVRFHMDSETHDPIDLQT |
| Q9Y2U5 | S239 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | SLDSPLDGESYPKSRMPRAQsyPDNHQEFSDyDNPIFEKFG |
| Q9Y316 | S91 | Sugiyama | MEMO1 C2orf4 MEMO NS5ATP7 CGI-27 | TRRIFILGPSHHVPLsRCALsSVDIYRTPLYDLRIDQKIYG |
| Q9Y394 | S328 | Sugiyama | DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448 | ITNKMGKKRIENFKSGVDADssyFKIFKTKHD_________ |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y3F4 | T109 | Sugiyama | STRAP MAWD UNRIP | VSGDELMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDL |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y3S2 | S27 | Sugiyama | ZNF330 NOA36 | GARKKAENRREREKQLRAsRstIDLAKHPCNASMECDKCQR |
| Q9Y3S2 | S310 | Sugiyama | ZNF330 NOA36 | DsDtEssDLFTNLNLGRTYAsGYAHyEEQEN__________ |
| Q9Y450 | S69 | Sugiyama | HBS1L HBS1 KIAA1038 | sVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDHMR |
| Q9Y490 | S1535 | Sugiyama | TLN1 KIAA1027 TLN | RTTNPTAKRQFVQSAKEVANsTANLVKTIKALDGAFTEENR |
| Q9Y4G6 | S1537 | Sugiyama | TLN2 KIAA0320 | KTANPVAKRHFVQSAKEVANsTANLVKTIKALDGDFSEDNR |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y4W2 | S636 | Sugiyama | LAS1L MSTP060 | EsPtAENARLLAQKRGALQGsAWQVssEDVRWDTFPLGRMP |
| Q9Y4X5 | S517 | Sugiyama | ARIH1 ARI MOP6 UBCH7BP HUSSY-27 | DLENATEVLSGYLERDIsQDsLQDIKQKVQDKYRYCESRRR |
| Q9Y5S2 | S221 | Sugiyama | CDC42BPB KIAA1124 | IKPDNVLLDVNGHIRLADFGsCLKMNDDGTVQSSVAVGTPD |
| Q9Y5S2 | S474 | Sugiyama | CDC42BPB KIAA1124 | KLELSRKLQESTQTVQsLHGsSRALSNsNRDKEIKKLNEEI |
| Q9Y696 | S226 | Sugiyama | CLIC4 | RNFDIPKEMTGIWRYLtNAysRDEFtNtCPsDKEVEIAysD |
| Q9Y6E0 | S400 | Sugiyama | STK24 MST3 STK3 | ISPLFAELKEKsQACGGNLGsIEELRGAIYLAEEACPGISD |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 6.046386e-12 | 11.219 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.496927e-09 | 8.260 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.088710e-08 | 7.963 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.810057e-08 | 7.167 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.925823e-08 | 7.160 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.079072e-07 | 6.682 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.332579e-07 | 6.030 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.305406e-07 | 6.031 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.821147e-06 | 5.550 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.292869e-06 | 5.482 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.256399e-06 | 5.487 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.741052e-06 | 5.427 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.619060e-06 | 5.335 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.962863e-06 | 5.304 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.005385e-05 | 4.998 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.109344e-05 | 4.955 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.517202e-05 | 4.819 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.242088e-05 | 4.649 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.347566e-05 | 4.629 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.473753e-05 | 4.607 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.213391e-05 | 4.493 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.629750e-05 | 4.440 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.549076e-05 | 4.342 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.949025e-05 | 4.305 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.949025e-05 | 4.305 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.684212e-05 | 4.245 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.218059e-05 | 4.206 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.218059e-05 | 4.206 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.684212e-05 | 4.245 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.184932e-05 | 4.209 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.535726e-05 | 4.257 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.811867e-05 | 4.167 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.536411e-05 | 4.069 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.433751e-05 | 4.074 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.343148e-05 | 4.030 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.026397e-04 | 3.989 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.035836e-04 | 3.985 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.158913e-04 | 3.936 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.158913e-04 | 3.936 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.123684e-04 | 3.949 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.317923e-04 | 3.880 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.317923e-04 | 3.880 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.511738e-04 | 3.821 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.565902e-04 | 3.805 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.860595e-04 | 3.730 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.987967e-04 | 3.702 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.481866e-04 | 3.605 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.146177e-04 | 3.502 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.750092e-04 | 3.426 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.368195e-04 | 3.360 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.320686e-04 | 3.364 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.444617e-04 | 3.264 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.384309e-04 | 3.132 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.103219e-04 | 3.091 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.075658e-04 | 3.093 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.100272e-04 | 3.092 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.865567e-04 | 3.104 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.336938e-04 | 3.079 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.960883e-04 | 3.048 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 9.684640e-04 | 3.014 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.019047e-03 | 2.992 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.106059e-03 | 2.956 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.105159e-03 | 2.957 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.107393e-03 | 2.956 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.116642e-03 | 2.952 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.199051e-03 | 2.921 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.267952e-03 | 2.897 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.372762e-03 | 2.862 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.513217e-03 | 2.820 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.559211e-03 | 2.807 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.787175e-03 | 2.748 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.787175e-03 | 2.748 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.839912e-03 | 2.735 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.965951e-03 | 2.706 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.925970e-03 | 2.715 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.886321e-03 | 2.724 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.070457e-03 | 2.684 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.223874e-03 | 2.653 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.223874e-03 | 2.653 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.223874e-03 | 2.653 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.142327e-03 | 2.669 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.223874e-03 | 2.653 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.518788e-03 | 2.599 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.585601e-03 | 2.587 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.473523e-03 | 2.607 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.599487e-03 | 2.585 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.812757e-03 | 2.551 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.280881e-03 | 2.484 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.333772e-03 | 2.477 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.396446e-03 | 2.469 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.891281e-03 | 2.410 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.884962e-03 | 2.411 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.894169e-03 | 2.410 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.894169e-03 | 2.410 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.894169e-03 | 2.410 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.842322e-03 | 2.415 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.224828e-03 | 2.374 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.166929e-03 | 2.380 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.340879e-03 | 2.362 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.369235e-03 | 2.360 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.650612e-03 | 2.332 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.184837e-03 | 2.285 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.061517e-03 | 2.296 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.184837e-03 | 2.285 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.391596e-03 | 2.268 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.429667e-03 | 2.265 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.469476e-03 | 2.262 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.586871e-03 | 2.253 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.586871e-03 | 2.253 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.855881e-03 | 2.232 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.513713e-03 | 2.259 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.557251e-03 | 2.255 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.965799e-03 | 2.224 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.035683e-03 | 2.219 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.512282e-03 | 2.186 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.793749e-03 | 2.168 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.957592e-03 | 2.158 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.856459e-03 | 2.164 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.856459e-03 | 2.164 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.840239e-03 | 2.165 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.856459e-03 | 2.164 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.379324e-03 | 2.132 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.381813e-03 | 2.132 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.044962e-03 | 2.094 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.044962e-03 | 2.094 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.188638e-03 | 2.087 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.336425e-03 | 2.079 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.764829e-03 | 2.057 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.895428e-03 | 2.051 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.124099e-03 | 2.040 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.271466e-03 | 2.033 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.416575e-03 | 2.026 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.466758e-03 | 2.024 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.003895e-02 | 1.998 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.091501e-02 | 1.962 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.091501e-02 | 1.962 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.091501e-02 | 1.962 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.020071e-02 | 1.991 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.082690e-02 | 1.965 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.082690e-02 | 1.965 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.082690e-02 | 1.965 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.090245e-02 | 1.962 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.027030e-02 | 1.988 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.098915e-02 | 1.959 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.117503e-02 | 1.952 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.120539e-02 | 1.951 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.130015e-02 | 1.947 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.169785e-02 | 1.932 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.286186e-02 | 1.891 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.240523e-02 | 1.906 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.240523e-02 | 1.906 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.279939e-02 | 1.893 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.239580e-02 | 1.907 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.273218e-02 | 1.895 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.414312e-02 | 1.849 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.414312e-02 | 1.849 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.414504e-02 | 1.849 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.458141e-02 | 1.836 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.458141e-02 | 1.836 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.555202e-02 | 1.808 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.600678e-02 | 1.796 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.600678e-02 | 1.796 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.545883e-02 | 1.811 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.632554e-02 | 1.787 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.531661e-02 | 1.815 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.600678e-02 | 1.796 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.600678e-02 | 1.796 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.714900e-02 | 1.766 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.719728e-02 | 1.765 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.965804e-02 | 1.706 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.965804e-02 | 1.706 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.965804e-02 | 1.706 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.965804e-02 | 1.706 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.965804e-02 | 1.706 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.965804e-02 | 1.706 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.965804e-02 | 1.706 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.965804e-02 | 1.706 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.965804e-02 | 1.706 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.965804e-02 | 1.706 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.965804e-02 | 1.706 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.813580e-02 | 1.741 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.813580e-02 | 1.741 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.955176e-02 | 1.709 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.791381e-02 | 1.747 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.816825e-02 | 1.741 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.813580e-02 | 1.741 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.791381e-02 | 1.747 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.967461e-02 | 1.706 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.968758e-02 | 1.706 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.033980e-02 | 1.692 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.058124e-02 | 1.687 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.062520e-02 | 1.686 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.062520e-02 | 1.686 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.070952e-02 | 1.684 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.096335e-02 | 1.679 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 2.096335e-02 | 1.679 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.098350e-02 | 1.678 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.098350e-02 | 1.678 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.098350e-02 | 1.678 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.120206e-02 | 1.674 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.215285e-02 | 1.655 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.137317e-02 | 1.670 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.392950e-02 | 1.621 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.281549e-02 | 1.642 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.333237e-02 | 1.632 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.215285e-02 | 1.655 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.393065e-02 | 1.621 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.428929e-02 | 1.615 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.428929e-02 | 1.615 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.428929e-02 | 1.615 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.776499e-02 | 1.557 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.776499e-02 | 1.557 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.752375e-02 | 1.560 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.752375e-02 | 1.560 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.752375e-02 | 1.560 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.752375e-02 | 1.560 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.752375e-02 | 1.560 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.507318e-02 | 1.601 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.751498e-02 | 1.560 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.751498e-02 | 1.560 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.480706e-02 | 1.605 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.480706e-02 | 1.605 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.507318e-02 | 1.601 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.800276e-02 | 1.553 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.752375e-02 | 1.560 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.507318e-02 | 1.601 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.615314e-02 | 1.582 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.611696e-02 | 1.583 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.594398e-02 | 1.586 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.684723e-02 | 1.571 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.684723e-02 | 1.571 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.495986e-02 | 1.603 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.752375e-02 | 1.560 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.786924e-02 | 1.555 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.751498e-02 | 1.560 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.815302e-02 | 1.550 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.818958e-02 | 1.550 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.872346e-02 | 1.542 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 2.898361e-02 | 1.538 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.898361e-02 | 1.538 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.905710e-02 | 1.537 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.906441e-02 | 1.537 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.923691e-02 | 1.534 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.080760e-02 | 1.511 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.297143e-02 | 1.482 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.297143e-02 | 1.482 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.297143e-02 | 1.482 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.297143e-02 | 1.482 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.297143e-02 | 1.482 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.297143e-02 | 1.482 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.297143e-02 | 1.482 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.467000e-02 | 1.460 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.531346e-02 | 1.452 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.138868e-02 | 1.503 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.436923e-02 | 1.464 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.389581e-02 | 1.470 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.389581e-02 | 1.470 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.536961e-02 | 1.451 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.100057e-02 | 1.509 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.156469e-02 | 1.501 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.536961e-02 | 1.451 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.384763e-02 | 1.470 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.211128e-02 | 1.493 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.531346e-02 | 1.452 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.614787e-02 | 1.442 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.430904e-02 | 1.465 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.385255e-02 | 1.470 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.305919e-02 | 1.481 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.531346e-02 | 1.452 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.592821e-02 | 1.445 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.508424e-02 | 1.455 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.508424e-02 | 1.455 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 3.536961e-02 | 1.451 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.731617e-02 | 1.428 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.868265e-02 | 1.412 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.868968e-02 | 1.412 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.911901e-02 | 1.408 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.121523e-02 | 1.385 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.212588e-02 | 1.375 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.256063e-02 | 1.371 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.312830e-02 | 1.365 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.379592e-02 | 1.359 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.409314e-02 | 1.356 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.479864e-02 | 1.349 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.495266e-02 | 1.347 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.512684e-02 | 1.346 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.649538e-02 | 1.333 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.702110e-02 | 1.328 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.702110e-02 | 1.328 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.820794e-02 | 1.317 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.820794e-02 | 1.317 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.888061e-02 | 1.311 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.014405e-02 | 1.300 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.014405e-02 | 1.300 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.014405e-02 | 1.300 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.014405e-02 | 1.300 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.014405e-02 | 1.300 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.414266e-02 | 1.266 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.414266e-02 | 1.266 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.469533e-02 | 1.262 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.480943e-02 | 1.261 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.331502e-02 | 1.273 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.331502e-02 | 1.273 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 5.118952e-02 | 1.291 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.091499e-02 | 1.215 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.428937e-02 | 1.265 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.903253e-02 | 1.229 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.715573e-02 | 1.243 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.356080e-02 | 1.271 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.480943e-02 | 1.261 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.567070e-02 | 1.254 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.897036e-02 | 1.229 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.331502e-02 | 1.273 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.971804e-02 | 1.224 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.331502e-02 | 1.273 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.977041e-02 | 1.224 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.469533e-02 | 1.262 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.428937e-02 | 1.265 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.897036e-02 | 1.229 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.357988e-02 | 1.271 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.315070e-02 | 1.200 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.339378e-02 | 1.198 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.339378e-02 | 1.198 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.339378e-02 | 1.198 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.339378e-02 | 1.198 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.339378e-02 | 1.198 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.339378e-02 | 1.198 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.339378e-02 | 1.198 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.395231e-02 | 1.194 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.395231e-02 | 1.194 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.411770e-02 | 1.193 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.416547e-02 | 1.193 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.564285e-02 | 1.183 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.605848e-02 | 1.180 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.658092e-02 | 1.177 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.772960e-02 | 1.169 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 6.772960e-02 | 1.169 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 6.772960e-02 | 1.169 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 6.772960e-02 | 1.169 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.772960e-02 | 1.169 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.200338e-02 | 1.143 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.200338e-02 | 1.143 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.271270e-02 | 1.138 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.271270e-02 | 1.138 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.271270e-02 | 1.138 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.271270e-02 | 1.138 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.776566e-02 | 1.109 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.175525e-02 | 1.037 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.175525e-02 | 1.037 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.842198e-02 | 1.106 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.842198e-02 | 1.106 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.842198e-02 | 1.106 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.971175e-02 | 1.098 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.847095e-02 | 1.105 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.776199e-02 | 1.057 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.542569e-02 | 1.068 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.779100e-02 | 1.057 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.961919e-02 | 1.099 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.887978e-02 | 1.103 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.887978e-02 | 1.103 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.268998e-02 | 1.083 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.740376e-02 | 1.111 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.609405e-02 | 1.119 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.908091e-02 | 1.050 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.986542e-02 | 1.046 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 9.175525e-02 | 1.037 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.171768e-02 | 1.088 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.813112e-02 | 1.107 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.071526e-02 | 1.093 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.268998e-02 | 1.083 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.787785e-02 | 1.109 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.787785e-02 | 1.109 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.779100e-02 | 1.057 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.069801e-02 | 1.093 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 9.175525e-02 | 1.037 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.054559e-02 | 1.094 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.425317e-02 | 1.074 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 7.776566e-02 | 1.109 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.776566e-02 | 1.109 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.175525e-02 | 1.037 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.227548e-02 | 1.085 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.406289e-02 | 1.130 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.435600e-02 | 1.129 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 9.175525e-02 | 1.037 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.539195e-02 | 1.069 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.226548e-02 | 1.035 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.345010e-02 | 1.029 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 9.418554e-02 | 1.026 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.435050e-02 | 1.025 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 9.518564e-02 | 1.021 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 9.518564e-02 | 1.021 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.922773e-02 | 1.003 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.922773e-02 | 1.003 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.922773e-02 | 1.003 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.946150e-02 | 1.002 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.015527e-01 | 0.993 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.314323e-01 | 0.881 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.314323e-01 | 0.881 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.314323e-01 | 0.881 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.100566e-01 | 0.958 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.100566e-01 | 0.958 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.100566e-01 | 0.958 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 1.050860e-01 | 0.978 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.050860e-01 | 0.978 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.355702e-01 | 0.868 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.355702e-01 | 0.868 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.355702e-01 | 0.868 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.137892e-01 | 0.944 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.137892e-01 | 0.944 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.137892e-01 | 0.944 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.336033e-01 | 0.874 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.336033e-01 | 0.874 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.099679e-01 | 0.959 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.099679e-01 | 0.959 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.099679e-01 | 0.959 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.048768e-01 | 0.979 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.270077e-01 | 0.896 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.207398e-01 | 0.918 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.330663e-01 | 0.876 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.353647e-01 | 0.868 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.205627e-01 | 0.919 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.230033e-01 | 0.910 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.191655e-01 | 0.924 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.326608e-01 | 0.877 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.129452e-01 | 0.947 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.172950e-01 | 0.931 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.049886e-01 | 0.979 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.158945e-01 | 0.936 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.191655e-01 | 0.924 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.090725e-01 | 0.962 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.230033e-01 | 0.910 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.243865e-01 | 0.905 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.099679e-01 | 0.959 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.050860e-01 | 0.978 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.073151e-01 | 0.969 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.283666e-01 | 0.892 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.050910e-01 | 0.978 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.099679e-01 | 0.959 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.156835e-01 | 0.937 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.050860e-01 | 0.978 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.050860e-01 | 0.978 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.136122e-01 | 0.945 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.147149e-01 | 0.940 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.266121e-01 | 0.898 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.251029e-01 | 0.903 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.353647e-01 | 0.868 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.190333e-01 | 0.924 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.050860e-01 | 0.978 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 1.100566e-01 | 0.958 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.270077e-01 | 0.896 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.038211e-01 | 0.984 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.336033e-01 | 0.874 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.067206e-01 | 0.972 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.177457e-01 | 0.929 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.354680e-01 | 0.868 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.119194e-01 | 0.951 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.215622e-01 | 0.915 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.049886e-01 | 0.979 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.137892e-01 | 0.944 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.303533e-01 | 0.885 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.365224e-01 | 0.865 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.379004e-01 | 0.860 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.383858e-01 | 0.859 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.408313e-01 | 0.851 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.433871e-01 | 0.843 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.433871e-01 | 0.843 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.435662e-01 | 0.843 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.447441e-01 | 0.839 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.452394e-01 | 0.838 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.452394e-01 | 0.838 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.452394e-01 | 0.838 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.452394e-01 | 0.838 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.452394e-01 | 0.838 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.458633e-01 | 0.836 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.458633e-01 | 0.836 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.460351e-01 | 0.836 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.460351e-01 | 0.836 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.469194e-01 | 0.833 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.470681e-01 | 0.832 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.470681e-01 | 0.832 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 1.522345e-01 | 0.817 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 1.522345e-01 | 0.817 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.550397e-01 | 0.810 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.550397e-01 | 0.810 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.550397e-01 | 0.810 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 1.550397e-01 | 0.810 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.563687e-01 | 0.806 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 1.573642e-01 | 0.803 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.573642e-01 | 0.803 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.591737e-01 | 0.798 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 1.596252e-01 | 0.797 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.596252e-01 | 0.797 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.076132e-01 | 0.683 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.076132e-01 | 0.683 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.686500e-01 | 0.773 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.686500e-01 | 0.773 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.686500e-01 | 0.773 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 1.686500e-01 | 0.773 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.037553e-01 | 0.691 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.037553e-01 | 0.691 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 2.037553e-01 | 0.691 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.638531e-01 | 0.786 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.913910e-01 | 0.718 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.913910e-01 | 0.718 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.403369e-01 | 0.619 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.403369e-01 | 0.619 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.403369e-01 | 0.619 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.403369e-01 | 0.619 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.777849e-01 | 0.750 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.202478e-01 | 0.657 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.645841e-01 | 0.784 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.016898e-01 | 0.695 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.016898e-01 | 0.695 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 2.016898e-01 | 0.695 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.726776e-01 | 0.763 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.074176e-01 | 0.683 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.074176e-01 | 0.683 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.074176e-01 | 0.683 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.277301e-01 | 0.643 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.277301e-01 | 0.643 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.277301e-01 | 0.643 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.824588e-01 | 0.739 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.743417e-01 | 0.759 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.266432e-01 | 0.645 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.656479e-01 | 0.781 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.779962e-01 | 0.750 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.219319e-01 | 0.654 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.211788e-01 | 0.655 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.939281e-01 | 0.712 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.861479e-01 | 0.730 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.265969e-01 | 0.645 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.073507e-01 | 0.683 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.824588e-01 | 0.739 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.686500e-01 | 0.773 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.726776e-01 | 0.763 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.122958e-01 | 0.673 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.869147e-01 | 0.728 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.828130e-01 | 0.738 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.219951e-01 | 0.654 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.775420e-01 | 0.751 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.894823e-01 | 0.722 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.701279e-01 | 0.769 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 1.737978e-01 | 0.760 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.257410e-01 | 0.646 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.887064e-01 | 0.724 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.076132e-01 | 0.683 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.686500e-01 | 0.773 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 2.403369e-01 | 0.619 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.065418e-01 | 0.685 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.015610e-01 | 0.696 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.084310e-01 | 0.681 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.074176e-01 | 0.683 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.884319e-01 | 0.725 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.983515e-01 | 0.703 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.076132e-01 | 0.683 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 2.037553e-01 | 0.691 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.265969e-01 | 0.645 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.277301e-01 | 0.643 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.082562e-01 | 0.681 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.192395e-01 | 0.659 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.359135e-01 | 0.627 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.869147e-01 | 0.728 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.884319e-01 | 0.725 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.257410e-01 | 0.646 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.957616e-01 | 0.708 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.895979e-01 | 0.722 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.726776e-01 | 0.763 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.229433e-01 | 0.652 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.403369e-01 | 0.619 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.777849e-01 | 0.750 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.257410e-01 | 0.646 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.257410e-01 | 0.646 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.173898e-01 | 0.663 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.277301e-01 | 0.643 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.196532e-01 | 0.658 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.359135e-01 | 0.627 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.753303e-01 | 0.756 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.967142e-01 | 0.706 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.897112e-01 | 0.722 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.032252e-01 | 0.692 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 2.403369e-01 | 0.619 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.777849e-01 | 0.750 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 2.037553e-01 | 0.691 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.403369e-01 | 0.619 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.265969e-01 | 0.645 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.265969e-01 | 0.645 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.077302e-01 | 0.683 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.738119e-01 | 0.760 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.059941e-01 | 0.686 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.257410e-01 | 0.646 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.229433e-01 | 0.652 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.976006e-01 | 0.704 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.853513e-01 | 0.732 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.885669e-01 | 0.725 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.869147e-01 | 0.728 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 2.333411e-01 | 0.632 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.202478e-01 | 0.657 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.884319e-01 | 0.725 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.720366e-01 | 0.764 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.403369e-01 | 0.619 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.283607e-01 | 0.641 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.038587e-01 | 0.691 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.265969e-01 | 0.645 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.699101e-01 | 0.770 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.913910e-01 | 0.718 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.040134e-01 | 0.690 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.446218e-01 | 0.612 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.446218e-01 | 0.612 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.455968e-01 | 0.610 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.455968e-01 | 0.610 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.455968e-01 | 0.610 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.455968e-01 | 0.610 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.455968e-01 | 0.610 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.469272e-01 | 0.607 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.469375e-01 | 0.607 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.483528e-01 | 0.605 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.483528e-01 | 0.605 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.483528e-01 | 0.605 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.483528e-01 | 0.605 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.447613e-01 | 0.462 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.447613e-01 | 0.462 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.447613e-01 | 0.462 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.447613e-01 | 0.462 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.447613e-01 | 0.462 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.447613e-01 | 0.462 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.447613e-01 | 0.462 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.447613e-01 | 0.462 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.447613e-01 | 0.462 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.447613e-01 | 0.462 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.447613e-01 | 0.462 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.447613e-01 | 0.462 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.447613e-01 | 0.462 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.592142e-01 | 0.586 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.592142e-01 | 0.586 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.592142e-01 | 0.586 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.592142e-01 | 0.586 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.109443e-01 | 0.507 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.109443e-01 | 0.507 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.109443e-01 | 0.507 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.109443e-01 | 0.507 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 3.109443e-01 | 0.507 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.308958e-01 | 0.366 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.308958e-01 | 0.366 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.308958e-01 | 0.366 | 0 | 0 |
| Essential pentosuria | R-HSA-5662853 | 4.308958e-01 | 0.366 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.308958e-01 | 0.366 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.308958e-01 | 0.366 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.308958e-01 | 0.366 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.778824e-01 | 0.556 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.778824e-01 | 0.556 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.778824e-01 | 0.556 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.778824e-01 | 0.556 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.501545e-01 | 0.602 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.618786e-01 | 0.441 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.618786e-01 | 0.441 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.618786e-01 | 0.441 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.808464e-01 | 0.552 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.808464e-01 | 0.552 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.523434e-01 | 0.598 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.511862e-01 | 0.600 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.787654e-01 | 0.555 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.120687e-01 | 0.506 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.120687e-01 | 0.506 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.540489e-01 | 0.451 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.540489e-01 | 0.451 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.540489e-01 | 0.451 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.540489e-01 | 0.451 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.113328e-01 | 0.386 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.113328e-01 | 0.386 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.113328e-01 | 0.386 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.113328e-01 | 0.386 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.113328e-01 | 0.386 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.113328e-01 | 0.386 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.113328e-01 | 0.386 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.746102e-01 | 0.561 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.057001e-01 | 0.515 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.057001e-01 | 0.515 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.057001e-01 | 0.515 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.435803e-01 | 0.464 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.435803e-01 | 0.464 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.695164e-01 | 0.569 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.695164e-01 | 0.569 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.985196e-01 | 0.525 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.918912e-01 | 0.407 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.918912e-01 | 0.407 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.639980e-01 | 0.578 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.228014e-01 | 0.491 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.228014e-01 | 0.491 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.751572e-01 | 0.426 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.751572e-01 | 0.426 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.588162e-01 | 0.338 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.588162e-01 | 0.338 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.588162e-01 | 0.338 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.588162e-01 | 0.338 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.588162e-01 | 0.338 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.131313e-01 | 0.504 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.131313e-01 | 0.504 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.604786e-01 | 0.443 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.604786e-01 | 0.443 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.604786e-01 | 0.443 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.473447e-01 | 0.459 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.473447e-01 | 0.459 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.473447e-01 | 0.459 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.291415e-01 | 0.367 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.291415e-01 | 0.367 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.244522e-01 | 0.489 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.720419e-01 | 0.429 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.720419e-01 | 0.429 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.579026e-01 | 0.446 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.451597e-01 | 0.462 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.451597e-01 | 0.462 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.451597e-01 | 0.462 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.623421e-01 | 0.581 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.299137e-01 | 0.482 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.805158e-01 | 0.420 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.805158e-01 | 0.420 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.154916e-01 | 0.381 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.377069e-01 | 0.359 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.377069e-01 | 0.359 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.655398e-01 | 0.332 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.655398e-01 | 0.332 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.472114e-01 | 0.459 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.472114e-01 | 0.459 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.870177e-01 | 0.412 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.870177e-01 | 0.412 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.214889e-01 | 0.375 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 4.427532e-01 | 0.354 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.683311e-01 | 0.329 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.683311e-01 | 0.329 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.683311e-01 | 0.329 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.997183e-01 | 0.523 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.696948e-01 | 0.328 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.843505e-01 | 0.415 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 4.983237e-01 | 0.302 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 4.983237e-01 | 0.302 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.962128e-01 | 0.304 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.165426e-01 | 0.380 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.165426e-01 | 0.380 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.424848e-01 | 0.465 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.901055e-01 | 0.310 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.901055e-01 | 0.310 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.165426e-01 | 0.380 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.039788e-01 | 0.517 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.959092e-01 | 0.529 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.523434e-01 | 0.598 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.451597e-01 | 0.462 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.451597e-01 | 0.462 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.214889e-01 | 0.375 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.291415e-01 | 0.367 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.523434e-01 | 0.598 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.696948e-01 | 0.328 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.492321e-01 | 0.457 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.660362e-01 | 0.436 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.610881e-01 | 0.442 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.435803e-01 | 0.464 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.720419e-01 | 0.429 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.746102e-01 | 0.561 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.918912e-01 | 0.407 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.384429e-01 | 0.358 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.196109e-01 | 0.377 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.778824e-01 | 0.556 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.501545e-01 | 0.602 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.985196e-01 | 0.525 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.460480e-01 | 0.351 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.253302e-01 | 0.371 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.696948e-01 | 0.328 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.335210e-01 | 0.477 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.738940e-01 | 0.562 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.778824e-01 | 0.556 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.511862e-01 | 0.600 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.065944e-01 | 0.391 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.953120e-01 | 0.530 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.100092e-01 | 0.509 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.109443e-01 | 0.507 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.778824e-01 | 0.556 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.778824e-01 | 0.556 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.501545e-01 | 0.602 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.751572e-01 | 0.426 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.604786e-01 | 0.443 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.429805e-01 | 0.465 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.928210e-01 | 0.307 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.149609e-01 | 0.382 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.398111e-01 | 0.357 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.377069e-01 | 0.359 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.588162e-01 | 0.338 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.291141e-01 | 0.483 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.441426e-01 | 0.463 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.031749e-01 | 0.395 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.285343e-01 | 0.368 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.592142e-01 | 0.586 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.618786e-01 | 0.441 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.540489e-01 | 0.451 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.918912e-01 | 0.407 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.918912e-01 | 0.407 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 3.918912e-01 | 0.407 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 4.655398e-01 | 0.332 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.330663e-01 | 0.477 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.700751e-01 | 0.328 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.985196e-01 | 0.525 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.918912e-01 | 0.407 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.870177e-01 | 0.412 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.364691e-01 | 0.360 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.921735e-01 | 0.407 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.683311e-01 | 0.329 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.451597e-01 | 0.462 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.412482e-01 | 0.467 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.118724e-01 | 0.385 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.118724e-01 | 0.385 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.349513e-01 | 0.475 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.308958e-01 | 0.366 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 4.113328e-01 | 0.386 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 4.113328e-01 | 0.386 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.751572e-01 | 0.426 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.751572e-01 | 0.426 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.588162e-01 | 0.338 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.588162e-01 | 0.338 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.588162e-01 | 0.338 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.291415e-01 | 0.367 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.795764e-01 | 0.553 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.983237e-01 | 0.302 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.944071e-01 | 0.306 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.435803e-01 | 0.464 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.473447e-01 | 0.459 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.720419e-01 | 0.429 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.451597e-01 | 0.462 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.451597e-01 | 0.462 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.587344e-01 | 0.445 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.899870e-01 | 0.409 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.120687e-01 | 0.506 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.985196e-01 | 0.525 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.868979e-01 | 0.542 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.646558e-01 | 0.438 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.646558e-01 | 0.438 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.646558e-01 | 0.438 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.646558e-01 | 0.438 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.787654e-01 | 0.555 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.540489e-01 | 0.451 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.113328e-01 | 0.386 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.751572e-01 | 0.426 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.131313e-01 | 0.504 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.655398e-01 | 0.332 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.683311e-01 | 0.329 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.703805e-01 | 0.328 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.986558e-01 | 0.525 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.154916e-01 | 0.381 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.592142e-01 | 0.586 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.720419e-01 | 0.429 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.696948e-01 | 0.328 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.808464e-01 | 0.552 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.542825e-01 | 0.343 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.615031e-01 | 0.336 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.751572e-01 | 0.426 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.566545e-01 | 0.448 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.080417e-01 | 0.389 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.703805e-01 | 0.328 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.110649e-01 | 0.386 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.592142e-01 | 0.586 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 3.109443e-01 | 0.507 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.109443e-01 | 0.507 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.308958e-01 | 0.366 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 4.308958e-01 | 0.366 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.308958e-01 | 0.366 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.308958e-01 | 0.366 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.308958e-01 | 0.366 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.113328e-01 | 0.386 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 4.113328e-01 | 0.386 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.985196e-01 | 0.525 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.639980e-01 | 0.578 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.329887e-01 | 0.478 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.588162e-01 | 0.338 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.588162e-01 | 0.338 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.696740e-01 | 0.569 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.880248e-01 | 0.411 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 4.655398e-01 | 0.332 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.593257e-01 | 0.445 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.258046e-01 | 0.371 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 3.964171e-01 | 0.402 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.707804e-01 | 0.327 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.998356e-01 | 0.398 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.100092e-01 | 0.509 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.031749e-01 | 0.395 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 2.501545e-01 | 0.602 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.808464e-01 | 0.552 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.329887e-01 | 0.478 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.499794e-01 | 0.347 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.646558e-01 | 0.438 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.429722e-01 | 0.465 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.751572e-01 | 0.426 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.588162e-01 | 0.338 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.131313e-01 | 0.504 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.604786e-01 | 0.443 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.354141e-01 | 0.474 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.707804e-01 | 0.327 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 4.833589e-01 | 0.316 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.655398e-01 | 0.332 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.258046e-01 | 0.371 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.882998e-01 | 0.411 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.699443e-01 | 0.569 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.556555e-01 | 0.592 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.109443e-01 | 0.507 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.308958e-01 | 0.366 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.778824e-01 | 0.556 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.159250e-01 | 0.500 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.720419e-01 | 0.429 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.707230e-01 | 0.327 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.473447e-01 | 0.459 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.377069e-01 | 0.359 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.420862e-01 | 0.354 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.720847e-01 | 0.565 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 4.291415e-01 | 0.367 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.291415e-01 | 0.367 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.329887e-01 | 0.478 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.065944e-01 | 0.391 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.427532e-01 | 0.354 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.308958e-01 | 0.366 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.113328e-01 | 0.386 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.588162e-01 | 0.338 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.131313e-01 | 0.504 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.880248e-01 | 0.411 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.640736e-01 | 0.439 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.501545e-01 | 0.602 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 2.696740e-01 | 0.569 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.109443e-01 | 0.507 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.113328e-01 | 0.386 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.913995e-01 | 0.309 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.154916e-01 | 0.381 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.748850e-01 | 0.323 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.962128e-01 | 0.304 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.008732e-01 | 0.300 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.008732e-01 | 0.300 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.008732e-01 | 0.300 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.008732e-01 | 0.300 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.008732e-01 | 0.300 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.008732e-01 | 0.300 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.008732e-01 | 0.300 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.008732e-01 | 0.300 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.039925e-01 | 0.298 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.039925e-01 | 0.298 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 5.039925e-01 | 0.298 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.039925e-01 | 0.298 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.039925e-01 | 0.298 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.039925e-01 | 0.298 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 5.039925e-01 | 0.298 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.039925e-01 | 0.298 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.042798e-01 | 0.297 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.051324e-01 | 0.297 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.057118e-01 | 0.296 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.057118e-01 | 0.296 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.057118e-01 | 0.296 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.057118e-01 | 0.296 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.057118e-01 | 0.296 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.057118e-01 | 0.296 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.057118e-01 | 0.296 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.057118e-01 | 0.296 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.057118e-01 | 0.296 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 5.057118e-01 | 0.296 | 0 | 0 |
| Defective CYP7B1 causes SPG5A and CBAS3 | R-HSA-5579013 | 5.057118e-01 | 0.296 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.057118e-01 | 0.296 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.057118e-01 | 0.296 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 5.057118e-01 | 0.296 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.057118e-01 | 0.296 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.057118e-01 | 0.296 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.093005e-01 | 0.293 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.117880e-01 | 0.291 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.141612e-01 | 0.289 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.146586e-01 | 0.288 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.180555e-01 | 0.286 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.187548e-01 | 0.285 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.222148e-01 | 0.282 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.222997e-01 | 0.282 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.275624e-01 | 0.278 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.275624e-01 | 0.278 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 5.275624e-01 | 0.278 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.275624e-01 | 0.278 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.275624e-01 | 0.278 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.349723e-01 | 0.272 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.349723e-01 | 0.272 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.349723e-01 | 0.272 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.349723e-01 | 0.272 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.349723e-01 | 0.272 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.361522e-01 | 0.271 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.412606e-01 | 0.267 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.466477e-01 | 0.262 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.466477e-01 | 0.262 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.466477e-01 | 0.262 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.466477e-01 | 0.262 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.466477e-01 | 0.262 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 5.466477e-01 | 0.262 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.466477e-01 | 0.262 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.466477e-01 | 0.262 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.466477e-01 | 0.262 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.466477e-01 | 0.262 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.466477e-01 | 0.262 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.469762e-01 | 0.262 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.476200e-01 | 0.262 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 5.476200e-01 | 0.262 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.486530e-01 | 0.261 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.488123e-01 | 0.261 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.509227e-01 | 0.259 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.559441e-01 | 0.255 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.559441e-01 | 0.255 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.560438e-01 | 0.255 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.560438e-01 | 0.255 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.639645e-01 | 0.249 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.677070e-01 | 0.246 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.677070e-01 | 0.246 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.677070e-01 | 0.246 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.677070e-01 | 0.246 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.681851e-01 | 0.246 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.683644e-01 | 0.245 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.706960e-01 | 0.244 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.706960e-01 | 0.244 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.706960e-01 | 0.244 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.706960e-01 | 0.244 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.706960e-01 | 0.244 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.706960e-01 | 0.244 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.706960e-01 | 0.244 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.706960e-01 | 0.244 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.706960e-01 | 0.244 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.706960e-01 | 0.244 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.706960e-01 | 0.244 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.706960e-01 | 0.244 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.706960e-01 | 0.244 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.706960e-01 | 0.244 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.706960e-01 | 0.244 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.710657e-01 | 0.243 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.711380e-01 | 0.243 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.725703e-01 | 0.242 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.748874e-01 | 0.240 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.773325e-01 | 0.239 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.803405e-01 | 0.236 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 5.833845e-01 | 0.234 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.833845e-01 | 0.234 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 5.833845e-01 | 0.234 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.834745e-01 | 0.234 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.836930e-01 | 0.234 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.866639e-01 | 0.232 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.866639e-01 | 0.232 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.866639e-01 | 0.232 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 5.866639e-01 | 0.232 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.866639e-01 | 0.232 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 5.866639e-01 | 0.232 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.866639e-01 | 0.232 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.866639e-01 | 0.232 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.866639e-01 | 0.232 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.866639e-01 | 0.232 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.866639e-01 | 0.232 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.866639e-01 | 0.232 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.866639e-01 | 0.232 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.963713e-01 | 0.224 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.981071e-01 | 0.223 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.981071e-01 | 0.223 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.012081e-01 | 0.221 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.012081e-01 | 0.221 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.048197e-01 | 0.218 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.098169e-01 | 0.215 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.098169e-01 | 0.215 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.098169e-01 | 0.215 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.142446e-01 | 0.212 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.160896e-01 | 0.210 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.177876e-01 | 0.209 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.177876e-01 | 0.209 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.177876e-01 | 0.209 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.205030e-01 | 0.207 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.237028e-01 | 0.205 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.239977e-01 | 0.205 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.239977e-01 | 0.205 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.239977e-01 | 0.205 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.239977e-01 | 0.205 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.239977e-01 | 0.205 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.239977e-01 | 0.205 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.258477e-01 | 0.204 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.270080e-01 | 0.203 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.271400e-01 | 0.203 | 0 | 0 |
| Defective CYP17A1 causes AH5 | R-HSA-5579028 | 6.271400e-01 | 0.203 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.271400e-01 | 0.203 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.271400e-01 | 0.203 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.271400e-01 | 0.203 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.271400e-01 | 0.203 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.271400e-01 | 0.203 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.271400e-01 | 0.203 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.271400e-01 | 0.203 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.271400e-01 | 0.203 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.271400e-01 | 0.203 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.271400e-01 | 0.203 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.271400e-01 | 0.203 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 6.271400e-01 | 0.203 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.271400e-01 | 0.203 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.271400e-01 | 0.203 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.271400e-01 | 0.203 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.271400e-01 | 0.203 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.271400e-01 | 0.203 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.275327e-01 | 0.202 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.287334e-01 | 0.202 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.287334e-01 | 0.202 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.287334e-01 | 0.202 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.287334e-01 | 0.202 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.287334e-01 | 0.202 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.288321e-01 | 0.201 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.351902e-01 | 0.197 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.351902e-01 | 0.197 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.351902e-01 | 0.197 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.351902e-01 | 0.197 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.351902e-01 | 0.197 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.351902e-01 | 0.197 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.369303e-01 | 0.196 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.369303e-01 | 0.196 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.420338e-01 | 0.192 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.420338e-01 | 0.192 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.482740e-01 | 0.188 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.488551e-01 | 0.188 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.488551e-01 | 0.188 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.519282e-01 | 0.186 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.520583e-01 | 0.186 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.520583e-01 | 0.186 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.520583e-01 | 0.186 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.520583e-01 | 0.186 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.555104e-01 | 0.183 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.569229e-01 | 0.182 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.569229e-01 | 0.182 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.569229e-01 | 0.182 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.569229e-01 | 0.182 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.569229e-01 | 0.182 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.569229e-01 | 0.182 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.586627e-01 | 0.181 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.586627e-01 | 0.181 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.586627e-01 | 0.181 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.586627e-01 | 0.181 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.586627e-01 | 0.181 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.586627e-01 | 0.181 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.586627e-01 | 0.181 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.586627e-01 | 0.181 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.586627e-01 | 0.181 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.586627e-01 | 0.181 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.586627e-01 | 0.181 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.586627e-01 | 0.181 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.586627e-01 | 0.181 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.586627e-01 | 0.181 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.594682e-01 | 0.181 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.619499e-01 | 0.179 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.636145e-01 | 0.178 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.636145e-01 | 0.178 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.684268e-01 | 0.175 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.684268e-01 | 0.175 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.736713e-01 | 0.172 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.741464e-01 | 0.171 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.761658e-01 | 0.170 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.761658e-01 | 0.170 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.761658e-01 | 0.170 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.761658e-01 | 0.170 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.761658e-01 | 0.170 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.761658e-01 | 0.170 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.761658e-01 | 0.170 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.761658e-01 | 0.170 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.761658e-01 | 0.170 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.761658e-01 | 0.170 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.761658e-01 | 0.170 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.761658e-01 | 0.170 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.761658e-01 | 0.170 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.761658e-01 | 0.170 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.761658e-01 | 0.170 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.761658e-01 | 0.170 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.761658e-01 | 0.170 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.761658e-01 | 0.170 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.786695e-01 | 0.168 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.786695e-01 | 0.168 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.799158e-01 | 0.168 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.826279e-01 | 0.166 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.826279e-01 | 0.166 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.826279e-01 | 0.166 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.835358e-01 | 0.165 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.835358e-01 | 0.165 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.843298e-01 | 0.165 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.843298e-01 | 0.165 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.854810e-01 | 0.164 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.872919e-01 | 0.163 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.884237e-01 | 0.162 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.888922e-01 | 0.162 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 6.907153e-01 | 0.161 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 6.907153e-01 | 0.161 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.907153e-01 | 0.161 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.907153e-01 | 0.161 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.907153e-01 | 0.161 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 6.907153e-01 | 0.161 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 6.907153e-01 | 0.161 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.907153e-01 | 0.161 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.907153e-01 | 0.161 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 6.907153e-01 | 0.161 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.032240e-01 | 0.153 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.041658e-01 | 0.152 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.046578e-01 | 0.152 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.046578e-01 | 0.152 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.046578e-01 | 0.152 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.085763e-01 | 0.150 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.085763e-01 | 0.150 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.085763e-01 | 0.150 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.085763e-01 | 0.150 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.085763e-01 | 0.150 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.106600e-01 | 0.148 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.171339e-01 | 0.144 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.187477e-01 | 0.143 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.187477e-01 | 0.143 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 7.187477e-01 | 0.143 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 7.187477e-01 | 0.143 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.187477e-01 | 0.143 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.187477e-01 | 0.143 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.187477e-01 | 0.143 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.187477e-01 | 0.143 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.187477e-01 | 0.143 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.187477e-01 | 0.143 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.187477e-01 | 0.143 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 7.202429e-01 | 0.143 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.202429e-01 | 0.143 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.202429e-01 | 0.143 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.202429e-01 | 0.143 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.202429e-01 | 0.143 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.202429e-01 | 0.143 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 7.202429e-01 | 0.143 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.202429e-01 | 0.143 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.202429e-01 | 0.143 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.202429e-01 | 0.143 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 7.202429e-01 | 0.143 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.202429e-01 | 0.143 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.231156e-01 | 0.141 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.231156e-01 | 0.141 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.238680e-01 | 0.140 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.240242e-01 | 0.140 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.256707e-01 | 0.139 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.256707e-01 | 0.139 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.306160e-01 | 0.136 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.314304e-01 | 0.136 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.320647e-01 | 0.135 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.320647e-01 | 0.135 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.320647e-01 | 0.135 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.394162e-01 | 0.131 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.394162e-01 | 0.131 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.395130e-01 | 0.131 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.395393e-01 | 0.131 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.402601e-01 | 0.131 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.411785e-01 | 0.130 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.411785e-01 | 0.130 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.414340e-01 | 0.130 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.431986e-01 | 0.129 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.453331e-01 | 0.128 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.453331e-01 | 0.128 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.458883e-01 | 0.127 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.473554e-01 | 0.126 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.473554e-01 | 0.126 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.473554e-01 | 0.126 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.473554e-01 | 0.126 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.473554e-01 | 0.126 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.473554e-01 | 0.126 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.473554e-01 | 0.126 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.473554e-01 | 0.126 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.473554e-01 | 0.126 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.473554e-01 | 0.126 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.473554e-01 | 0.126 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.473554e-01 | 0.126 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.540343e-01 | 0.123 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.540343e-01 | 0.123 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.540343e-01 | 0.123 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.540343e-01 | 0.123 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.540343e-01 | 0.123 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.540343e-01 | 0.123 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.540343e-01 | 0.123 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.540343e-01 | 0.123 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.543047e-01 | 0.122 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.543047e-01 | 0.122 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.543047e-01 | 0.122 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.543047e-01 | 0.122 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.543400e-01 | 0.122 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.543400e-01 | 0.122 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.554931e-01 | 0.122 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.557326e-01 | 0.122 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.557326e-01 | 0.122 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.557326e-01 | 0.122 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.557326e-01 | 0.122 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.557326e-01 | 0.122 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.557326e-01 | 0.122 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.557326e-01 | 0.122 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 7.557326e-01 | 0.122 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.557326e-01 | 0.122 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.557326e-01 | 0.122 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.557326e-01 | 0.122 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.557326e-01 | 0.122 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.557326e-01 | 0.122 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.557326e-01 | 0.122 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.557326e-01 | 0.122 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.557326e-01 | 0.122 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.557326e-01 | 0.122 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.583595e-01 | 0.120 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.619138e-01 | 0.118 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.641570e-01 | 0.117 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.678047e-01 | 0.115 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.707199e-01 | 0.113 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.707199e-01 | 0.113 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.707199e-01 | 0.113 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.721773e-01 | 0.112 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.721773e-01 | 0.112 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 7.721773e-01 | 0.112 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.721773e-01 | 0.112 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.721773e-01 | 0.112 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.721773e-01 | 0.112 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 7.721773e-01 | 0.112 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.745287e-01 | 0.111 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.745287e-01 | 0.111 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.745287e-01 | 0.111 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.746686e-01 | 0.111 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.814963e-01 | 0.107 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.815860e-01 | 0.107 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.817111e-01 | 0.107 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.823230e-01 | 0.107 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.852273e-01 | 0.105 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.878558e-01 | 0.104 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.878558e-01 | 0.104 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.878558e-01 | 0.104 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.878558e-01 | 0.104 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.878558e-01 | 0.104 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.878558e-01 | 0.104 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.878558e-01 | 0.104 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.878558e-01 | 0.104 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.878558e-01 | 0.104 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.878558e-01 | 0.104 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.878558e-01 | 0.104 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.878558e-01 | 0.104 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.878558e-01 | 0.104 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.878558e-01 | 0.104 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.878558e-01 | 0.104 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.878558e-01 | 0.104 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.901199e-01 | 0.102 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.901199e-01 | 0.102 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.901199e-01 | 0.102 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.935998e-01 | 0.100 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 7.935998e-01 | 0.100 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.940298e-01 | 0.100 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.948419e-01 | 0.100 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.948419e-01 | 0.100 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.948419e-01 | 0.100 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.948419e-01 | 0.100 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 7.948419e-01 | 0.100 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.948419e-01 | 0.100 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.948419e-01 | 0.100 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.975791e-01 | 0.098 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.981124e-01 | 0.098 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.981124e-01 | 0.098 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.019549e-01 | 0.096 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.043289e-01 | 0.095 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.043945e-01 | 0.095 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.050681e-01 | 0.094 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.080640e-01 | 0.093 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.128213e-01 | 0.090 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.136134e-01 | 0.090 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.154874e-01 | 0.089 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.154874e-01 | 0.089 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.154874e-01 | 0.089 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.154874e-01 | 0.089 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.157562e-01 | 0.088 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.157562e-01 | 0.088 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.157562e-01 | 0.088 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.157562e-01 | 0.088 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.157562e-01 | 0.088 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 8.157562e-01 | 0.088 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.157562e-01 | 0.088 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.157562e-01 | 0.088 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.157562e-01 | 0.088 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.157562e-01 | 0.088 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.161042e-01 | 0.088 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.161919e-01 | 0.088 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.185242e-01 | 0.087 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.185242e-01 | 0.087 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.185242e-01 | 0.087 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.185242e-01 | 0.087 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.217750e-01 | 0.085 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.245515e-01 | 0.084 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.246564e-01 | 0.084 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.277079e-01 | 0.082 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.281245e-01 | 0.082 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.281245e-01 | 0.082 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.281245e-01 | 0.082 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.296684e-01 | 0.081 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.301542e-01 | 0.081 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.315218e-01 | 0.080 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.315218e-01 | 0.080 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.315218e-01 | 0.080 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.342527e-01 | 0.079 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.342527e-01 | 0.079 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.342527e-01 | 0.079 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.342527e-01 | 0.079 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 8.342527e-01 | 0.079 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.342527e-01 | 0.079 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.363116e-01 | 0.078 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.398006e-01 | 0.076 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.399886e-01 | 0.076 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.399886e-01 | 0.076 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.399886e-01 | 0.076 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.399886e-01 | 0.076 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 8.399886e-01 | 0.076 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.399886e-01 | 0.076 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.399886e-01 | 0.076 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.399886e-01 | 0.076 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.399886e-01 | 0.076 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.399886e-01 | 0.076 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.399886e-01 | 0.076 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.399886e-01 | 0.076 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.399886e-01 | 0.076 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.428724e-01 | 0.074 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.428724e-01 | 0.074 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.428724e-01 | 0.074 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.428724e-01 | 0.074 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.428724e-01 | 0.074 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.428749e-01 | 0.074 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.437500e-01 | 0.074 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.437500e-01 | 0.074 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.473012e-01 | 0.072 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.474279e-01 | 0.072 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.485293e-01 | 0.071 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.505344e-01 | 0.070 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.512752e-01 | 0.070 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.512752e-01 | 0.070 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.512752e-01 | 0.070 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.512752e-01 | 0.070 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.524668e-01 | 0.069 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.532382e-01 | 0.069 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.538277e-01 | 0.069 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.543321e-01 | 0.068 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.552363e-01 | 0.068 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.568292e-01 | 0.067 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.568657e-01 | 0.067 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.589920e-01 | 0.066 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.610351e-01 | 0.065 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.610351e-01 | 0.065 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.610351e-01 | 0.065 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.610351e-01 | 0.065 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.610351e-01 | 0.065 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.610351e-01 | 0.065 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.610351e-01 | 0.065 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.610351e-01 | 0.065 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.610351e-01 | 0.065 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.610351e-01 | 0.065 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.635065e-01 | 0.064 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.645527e-01 | 0.063 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.660092e-01 | 0.062 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.661104e-01 | 0.062 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.661104e-01 | 0.062 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.666886e-01 | 0.062 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.666886e-01 | 0.062 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.666886e-01 | 0.062 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.666886e-01 | 0.062 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.666886e-01 | 0.062 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.666886e-01 | 0.062 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.666886e-01 | 0.062 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.678118e-01 | 0.062 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.697551e-01 | 0.061 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.697551e-01 | 0.061 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.770612e-01 | 0.057 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.770612e-01 | 0.057 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.770612e-01 | 0.057 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.771227e-01 | 0.057 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.793144e-01 | 0.056 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.793144e-01 | 0.056 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.793144e-01 | 0.056 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.793144e-01 | 0.056 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.793144e-01 | 0.056 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.793144e-01 | 0.056 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.793144e-01 | 0.056 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.806216e-01 | 0.055 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.806216e-01 | 0.055 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.806216e-01 | 0.055 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.806216e-01 | 0.055 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.816076e-01 | 0.055 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.816076e-01 | 0.055 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.816076e-01 | 0.055 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.855338e-01 | 0.053 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.858765e-01 | 0.053 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.872272e-01 | 0.052 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.872272e-01 | 0.052 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.924893e-01 | 0.049 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.931969e-01 | 0.049 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.931969e-01 | 0.049 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.951901e-01 | 0.048 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.951901e-01 | 0.048 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.951901e-01 | 0.048 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.951901e-01 | 0.048 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 8.951901e-01 | 0.048 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.951901e-01 | 0.048 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.951901e-01 | 0.048 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.951901e-01 | 0.048 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.951901e-01 | 0.048 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.951901e-01 | 0.048 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.951901e-01 | 0.048 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.024646e-01 | 0.045 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.025654e-01 | 0.045 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.030463e-01 | 0.044 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.045306e-01 | 0.044 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.045306e-01 | 0.044 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.045306e-01 | 0.044 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.045306e-01 | 0.044 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.053740e-01 | 0.043 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.053740e-01 | 0.043 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 9.089783e-01 | 0.041 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 9.089783e-01 | 0.041 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.089783e-01 | 0.041 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.089783e-01 | 0.041 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.089783e-01 | 0.041 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 9.089783e-01 | 0.041 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.089783e-01 | 0.041 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.089783e-01 | 0.041 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.089783e-01 | 0.041 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 9.089783e-01 | 0.041 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 9.089783e-01 | 0.041 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.090260e-01 | 0.041 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.091213e-01 | 0.041 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.134531e-01 | 0.039 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.147315e-01 | 0.039 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.147315e-01 | 0.039 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.147315e-01 | 0.039 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.147315e-01 | 0.039 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.157826e-01 | 0.038 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.157826e-01 | 0.038 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.167812e-01 | 0.038 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.199431e-01 | 0.036 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.199431e-01 | 0.036 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.199431e-01 | 0.036 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.208833e-01 | 0.036 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.208833e-01 | 0.036 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.208833e-01 | 0.036 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 9.209533e-01 | 0.036 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.209533e-01 | 0.036 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 9.209533e-01 | 0.036 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.209533e-01 | 0.036 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.209533e-01 | 0.036 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 9.209533e-01 | 0.036 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.209533e-01 | 0.036 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.231227e-01 | 0.035 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.239016e-01 | 0.034 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.239016e-01 | 0.034 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.239016e-01 | 0.034 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.239664e-01 | 0.034 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.239664e-01 | 0.034 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.242659e-01 | 0.034 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.275640e-01 | 0.033 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.275640e-01 | 0.033 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.275640e-01 | 0.033 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.275640e-01 | 0.033 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.275640e-01 | 0.033 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.277487e-01 | 0.033 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.277487e-01 | 0.033 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.313534e-01 | 0.031 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.313534e-01 | 0.031 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.313534e-01 | 0.031 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.313534e-01 | 0.031 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 9.313534e-01 | 0.031 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 9.313534e-01 | 0.031 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.313534e-01 | 0.031 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.313534e-01 | 0.031 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.314310e-01 | 0.031 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 9.321355e-01 | 0.031 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 9.321355e-01 | 0.031 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.321355e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.321355e-01 | 0.031 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.321355e-01 | 0.031 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.323844e-01 | 0.030 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.338394e-01 | 0.030 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.340719e-01 | 0.030 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.343147e-01 | 0.030 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.343147e-01 | 0.030 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.345130e-01 | 0.029 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.345130e-01 | 0.029 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 9.348088e-01 | 0.029 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.358102e-01 | 0.029 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.362442e-01 | 0.029 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.369643e-01 | 0.028 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.376405e-01 | 0.028 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.395206e-01 | 0.027 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.398891e-01 | 0.027 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.398891e-01 | 0.027 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.398891e-01 | 0.027 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.398891e-01 | 0.027 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.403857e-01 | 0.027 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.403857e-01 | 0.027 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.403857e-01 | 0.027 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.403857e-01 | 0.027 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.403857e-01 | 0.027 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.403857e-01 | 0.027 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.403857e-01 | 0.027 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.403857e-01 | 0.027 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.403857e-01 | 0.027 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.403857e-01 | 0.027 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.408420e-01 | 0.026 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.408420e-01 | 0.026 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.408420e-01 | 0.026 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.408420e-01 | 0.026 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.412013e-01 | 0.026 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.412665e-01 | 0.026 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.436551e-01 | 0.025 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.452349e-01 | 0.024 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.459043e-01 | 0.024 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.461378e-01 | 0.024 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.461378e-01 | 0.024 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.461378e-01 | 0.024 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.461831e-01 | 0.024 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.462269e-01 | 0.024 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.466889e-01 | 0.024 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.482300e-01 | 0.023 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.482300e-01 | 0.023 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.482300e-01 | 0.023 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.482300e-01 | 0.023 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 9.482300e-01 | 0.023 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.482300e-01 | 0.023 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.482300e-01 | 0.023 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.501423e-01 | 0.022 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.502457e-01 | 0.022 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.504862e-01 | 0.022 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.518327e-01 | 0.021 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.520613e-01 | 0.021 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.520613e-01 | 0.021 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.520613e-01 | 0.021 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.524493e-01 | 0.021 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.546426e-01 | 0.020 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.546426e-01 | 0.020 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.546551e-01 | 0.020 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.550425e-01 | 0.020 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.550425e-01 | 0.020 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.550425e-01 | 0.020 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.565834e-01 | 0.019 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.565834e-01 | 0.019 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.565834e-01 | 0.019 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.565834e-01 | 0.019 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.573590e-01 | 0.019 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.587657e-01 | 0.018 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.589034e-01 | 0.018 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.595381e-01 | 0.018 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.595437e-01 | 0.018 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.595437e-01 | 0.018 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.608921e-01 | 0.017 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.608921e-01 | 0.017 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.608921e-01 | 0.017 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.608921e-01 | 0.017 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.608921e-01 | 0.017 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.609589e-01 | 0.017 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.609589e-01 | 0.017 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.609589e-01 | 0.017 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.620929e-01 | 0.017 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.638383e-01 | 0.016 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.647964e-01 | 0.016 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.647964e-01 | 0.016 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.647964e-01 | 0.016 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.653115e-01 | 0.015 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.656383e-01 | 0.015 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.659904e-01 | 0.015 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.659904e-01 | 0.015 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.660970e-01 | 0.015 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.660970e-01 | 0.015 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.660970e-01 | 0.015 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.660970e-01 | 0.015 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.660970e-01 | 0.015 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.663198e-01 | 0.015 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.663198e-01 | 0.015 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.663198e-01 | 0.015 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.663198e-01 | 0.015 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.663198e-01 | 0.015 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.676357e-01 | 0.014 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.678739e-01 | 0.014 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.683311e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.683311e-01 | 0.014 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.693791e-01 | 0.014 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.700909e-01 | 0.013 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.705592e-01 | 0.013 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.705592e-01 | 0.013 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.705592e-01 | 0.013 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.705592e-01 | 0.013 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.720215e-01 | 0.012 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.734532e-01 | 0.012 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.734555e-01 | 0.012 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.736715e-01 | 0.012 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.738837e-01 | 0.011 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.738837e-01 | 0.011 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.744180e-01 | 0.011 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.744343e-01 | 0.011 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.744343e-01 | 0.011 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.744343e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.744343e-01 | 0.011 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.744343e-01 | 0.011 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.744343e-01 | 0.011 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.756725e-01 | 0.011 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.764487e-01 | 0.010 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.764487e-01 | 0.010 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.770277e-01 | 0.010 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.777995e-01 | 0.010 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.777995e-01 | 0.010 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.777995e-01 | 0.010 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 9.777995e-01 | 0.010 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.777995e-01 | 0.010 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.777995e-01 | 0.010 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.780802e-01 | 0.010 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.791158e-01 | 0.009 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.791158e-01 | 0.009 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.791158e-01 | 0.009 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.792180e-01 | 0.009 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.793826e-01 | 0.009 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.793826e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.796008e-01 | 0.009 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.800380e-01 | 0.009 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.802650e-01 | 0.009 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.807219e-01 | 0.008 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.807219e-01 | 0.008 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.812006e-01 | 0.008 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.812247e-01 | 0.008 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.813357e-01 | 0.008 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.813357e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.813357e-01 | 0.008 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.814891e-01 | 0.008 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.814891e-01 | 0.008 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.814891e-01 | 0.008 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.815061e-01 | 0.008 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.815061e-01 | 0.008 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.829321e-01 | 0.007 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.832598e-01 | 0.007 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.832598e-01 | 0.007 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.832598e-01 | 0.007 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.835996e-01 | 0.007 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.840281e-01 | 0.007 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.842447e-01 | 0.007 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.851426e-01 | 0.007 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.854637e-01 | 0.006 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.854637e-01 | 0.006 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.854637e-01 | 0.006 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.854637e-01 | 0.006 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.854754e-01 | 0.006 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.854754e-01 | 0.006 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.861292e-01 | 0.006 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.861358e-01 | 0.006 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.863443e-01 | 0.006 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.869827e-01 | 0.006 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.873775e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.873775e-01 | 0.006 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.873775e-01 | 0.006 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.873775e-01 | 0.006 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.874790e-01 | 0.005 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.881256e-01 | 0.005 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.887031e-01 | 0.005 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.888722e-01 | 0.005 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.890395e-01 | 0.005 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.890395e-01 | 0.005 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.890395e-01 | 0.005 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.890395e-01 | 0.005 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.891687e-01 | 0.005 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.893407e-01 | 0.005 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.904664e-01 | 0.004 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.904828e-01 | 0.004 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.904828e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.904828e-01 | 0.004 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.904828e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.904828e-01 | 0.004 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.904828e-01 | 0.004 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.916007e-01 | 0.004 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.917360e-01 | 0.004 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.917360e-01 | 0.004 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.917360e-01 | 0.004 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.920723e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.921309e-01 | 0.003 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.928243e-01 | 0.003 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.928243e-01 | 0.003 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.928243e-01 | 0.003 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.930193e-01 | 0.003 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.930607e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.930607e-01 | 0.003 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.930607e-01 | 0.003 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.931073e-01 | 0.003 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.931967e-01 | 0.003 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.932936e-01 | 0.003 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.937693e-01 | 0.003 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.943537e-01 | 0.002 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.945900e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.947532e-01 | 0.002 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.951212e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.951212e-01 | 0.002 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.954151e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.956157e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.959213e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.961537e-01 | 0.002 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.963506e-01 | 0.002 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.964586e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.968258e-01 | 0.001 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.969251e-01 | 0.001 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.969251e-01 | 0.001 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.969251e-01 | 0.001 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.969493e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.970791e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.970969e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.973302e-01 | 0.001 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.973815e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.974902e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.976820e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.979470e-01 | 0.001 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.979874e-01 | 0.001 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.979874e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.979874e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.979874e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.980787e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.980934e-01 | 0.001 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.981605e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.982526e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.982942e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.984829e-01 | 0.001 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.984829e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.985247e-01 | 0.001 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.985772e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.988564e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.989114e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.989353e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.989460e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.989462e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.990071e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.990307e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.990543e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.991074e-01 | 0.000 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.991380e-01 | 0.000 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.991380e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.991397e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.991838e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.992516e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.992545e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.992819e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.992819e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.993503e-01 | 0.000 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.993503e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.994323e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.995387e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.995748e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.996796e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997084e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.997084e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.997178e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.997218e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.997218e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.997438e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.997789e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.998023e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998079e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.998180e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998264e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998448e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998514e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998514e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998611e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998661e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998783e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998809e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998809e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998969e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.999221e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.999324e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.999413e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999530e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999558e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999558e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999572e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999616e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999616e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999616e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999667e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999683e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999784e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999858e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999858e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999874e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999876e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999930e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999941e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999943e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999947e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999952e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999956e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999957e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999957e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999964e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999967e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999974e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999977e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999983e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999984e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999985e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999989e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999989e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999993e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999995e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999998e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999998e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 9.287016e-13 | 12.032 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.121570e-11 | 10.385 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.221753e-10 | 9.913 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.197322e-10 | 9.495 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.386465e-10 | 9.132 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.676283e-10 | 9.115 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.371475e-09 | 8.863 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.708677e-09 | 8.767 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.629193e-09 | 8.788 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.144265e-09 | 8.383 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.588285e-09 | 8.338 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.042616e-08 | 7.982 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.409190e-08 | 7.618 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.715374e-08 | 7.566 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.715374e-08 | 7.566 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.715374e-08 | 7.566 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.715374e-08 | 7.566 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.239564e-08 | 7.650 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.715374e-08 | 7.566 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.350178e-08 | 7.361 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.391021e-08 | 7.357 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.258700e-08 | 7.279 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.943005e-08 | 7.226 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.899973e-08 | 7.161 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.578239e-08 | 7.120 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.247926e-08 | 7.034 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.247926e-08 | 7.034 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.220574e-07 | 6.913 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.411236e-07 | 6.850 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.209358e-07 | 6.656 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.885461e-07 | 6.540 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.306881e-07 | 6.481 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.306881e-07 | 6.481 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.164579e-07 | 6.500 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.218934e-07 | 6.492 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.863302e-07 | 6.413 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.951061e-07 | 6.403 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.538547e-07 | 6.343 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.065240e-07 | 6.295 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.655227e-07 | 6.248 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.141883e-06 | 5.942 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.245981e-06 | 5.904 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.387319e-06 | 5.858 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.473910e-06 | 5.832 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.026960e-06 | 5.693 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.301641e-06 | 5.638 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.434039e-06 | 5.614 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.919240e-06 | 5.535 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.311566e-06 | 5.480 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.328955e-06 | 5.478 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.485009e-06 | 5.458 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.549889e-06 | 5.450 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.882205e-06 | 5.230 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.759038e-06 | 5.240 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.082174e-06 | 5.216 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.691232e-06 | 5.174 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.190268e-06 | 5.087 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.230081e-06 | 5.085 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.510326e-06 | 5.070 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.102763e-05 | 4.958 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.126662e-05 | 4.948 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.271674e-05 | 4.896 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.231666e-05 | 4.910 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.409111e-05 | 4.851 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.483636e-05 | 4.829 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.483636e-05 | 4.829 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.555992e-05 | 4.808 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.555992e-05 | 4.808 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.685492e-05 | 4.773 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.833691e-05 | 4.737 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.923253e-05 | 4.716 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.380702e-05 | 4.623 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.382318e-05 | 4.623 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.594841e-05 | 4.586 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.594841e-05 | 4.586 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.637404e-05 | 4.579 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.641219e-05 | 4.578 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.951014e-05 | 4.530 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.207992e-05 | 4.494 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.239541e-05 | 4.490 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.200996e-05 | 4.495 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.297023e-05 | 4.482 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.639820e-05 | 4.439 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.629311e-05 | 4.440 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.488588e-05 | 4.457 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.570796e-05 | 4.447 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.568772e-05 | 4.340 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.604087e-05 | 4.337 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.629981e-05 | 4.334 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.604087e-05 | 4.337 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.670341e-05 | 4.331 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.794573e-05 | 4.319 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.894675e-05 | 4.310 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.981343e-05 | 4.303 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.418091e-05 | 4.266 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.458887e-05 | 4.263 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.468701e-05 | 4.262 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.775952e-05 | 4.238 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.043592e-05 | 4.219 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.738888e-05 | 4.171 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.639744e-05 | 4.178 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.699166e-05 | 4.174 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.802784e-05 | 4.167 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.858385e-05 | 4.164 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.427860e-05 | 4.129 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.427860e-05 | 4.129 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.591654e-05 | 4.120 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.583676e-05 | 4.120 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.591654e-05 | 4.120 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.619967e-05 | 4.064 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.675875e-05 | 4.062 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.178067e-05 | 4.037 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.246430e-05 | 4.034 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.464131e-05 | 4.024 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.073280e-04 | 3.969 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.073280e-04 | 3.969 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.071151e-04 | 3.970 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.126295e-04 | 3.948 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.208623e-04 | 3.918 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.162105e-04 | 3.935 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.220643e-04 | 3.913 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.208623e-04 | 3.918 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.197645e-04 | 3.922 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.245253e-04 | 3.905 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.281657e-04 | 3.892 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.301393e-04 | 3.886 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.301393e-04 | 3.886 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.404096e-04 | 3.853 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.420412e-04 | 3.848 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.472093e-04 | 3.832 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.476366e-04 | 3.831 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.663362e-04 | 3.779 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.548488e-04 | 3.810 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.669286e-04 | 3.777 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.551552e-04 | 3.809 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.832584e-04 | 3.737 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.843843e-04 | 3.734 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.864507e-04 | 3.729 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.908709e-04 | 3.719 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.011591e-04 | 3.696 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.023241e-04 | 3.694 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.262747e-04 | 3.645 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.345229e-04 | 3.630 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.244164e-04 | 3.649 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.370659e-04 | 3.625 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.370659e-04 | 3.625 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.413603e-04 | 3.617 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.536773e-04 | 3.596 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.536773e-04 | 3.596 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.549824e-04 | 3.593 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.714154e-04 | 3.566 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.754118e-04 | 3.560 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.867219e-04 | 3.543 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.867832e-04 | 3.542 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.986242e-04 | 3.525 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.001245e-04 | 3.523 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.009391e-04 | 3.522 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.275882e-04 | 3.485 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.524815e-04 | 3.453 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.251877e-04 | 3.488 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.510816e-04 | 3.455 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.524815e-04 | 3.453 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.805467e-04 | 3.420 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.002648e-04 | 3.398 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 4.128582e-04 | 3.384 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.274107e-04 | 3.369 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.497826e-04 | 3.347 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.589396e-04 | 3.338 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.647725e-04 | 3.333 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.647725e-04 | 3.333 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.647725e-04 | 3.333 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.772603e-04 | 3.321 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.174560e-04 | 3.286 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.755358e-04 | 3.240 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.755358e-04 | 3.240 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.456131e-04 | 3.263 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.755358e-04 | 3.240 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.590504e-04 | 3.253 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.755358e-04 | 3.240 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.683432e-04 | 3.245 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.774390e-04 | 3.238 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.073321e-04 | 3.217 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.115265e-04 | 3.214 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.301612e-04 | 3.201 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.680074e-04 | 3.175 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.694271e-04 | 3.174 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.876658e-04 | 3.163 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.335383e-04 | 3.135 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.335383e-04 | 3.135 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.418681e-04 | 3.130 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.506727e-04 | 3.125 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.506727e-04 | 3.125 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.579714e-04 | 3.120 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.527282e-04 | 3.123 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.434481e-04 | 3.074 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.506727e-04 | 3.125 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.499227e-04 | 3.071 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.523092e-04 | 3.069 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.900683e-04 | 3.051 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.900683e-04 | 3.051 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.454274e-04 | 3.024 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.006111e-03 | 2.997 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.015963e-03 | 2.993 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.056112e-03 | 2.976 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.056259e-03 | 2.976 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.084167e-03 | 2.965 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.087239e-03 | 2.964 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.090638e-03 | 2.962 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.095953e-03 | 2.960 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.222097e-03 | 2.913 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.224909e-03 | 2.912 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.308372e-03 | 2.883 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.326553e-03 | 2.877 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.344287e-03 | 2.872 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.366115e-03 | 2.865 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.466894e-03 | 2.834 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.418292e-03 | 2.848 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.548962e-03 | 2.810 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.546744e-03 | 2.811 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.595861e-03 | 2.797 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.619572e-03 | 2.791 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.670981e-03 | 2.777 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.744377e-03 | 2.758 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.744377e-03 | 2.758 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.744377e-03 | 2.758 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.744377e-03 | 2.758 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.752303e-03 | 2.756 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.895452e-03 | 2.722 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.912858e-03 | 2.718 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.951672e-03 | 2.710 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.988743e-03 | 2.701 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.000702e-03 | 2.699 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.025691e-03 | 2.693 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.130280e-03 | 2.672 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.173148e-03 | 2.663 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.225639e-03 | 2.653 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.225639e-03 | 2.653 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.326680e-03 | 2.633 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.513606e-03 | 2.600 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.628514e-03 | 2.580 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.750323e-03 | 2.561 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.840680e-03 | 2.547 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.936354e-03 | 2.532 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.536884e-03 | 2.596 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.790502e-03 | 2.554 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.746814e-03 | 2.561 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.662441e-03 | 2.575 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.529086e-03 | 2.597 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.629804e-03 | 2.580 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.685245e-03 | 2.571 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.840680e-03 | 2.547 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.705521e-03 | 2.568 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.628514e-03 | 2.580 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.524475e-03 | 2.598 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.027641e-03 | 2.519 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.046870e-03 | 2.516 | 0 | 0 |
| Translation | R-HSA-72766 | 3.108142e-03 | 2.507 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.153524e-03 | 2.501 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.160419e-03 | 2.500 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.187039e-03 | 2.497 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.238887e-03 | 2.490 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.357187e-03 | 2.474 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.437250e-03 | 2.464 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.561674e-03 | 2.448 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.638327e-03 | 2.439 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.645023e-03 | 2.438 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.700995e-03 | 2.432 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.700995e-03 | 2.432 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.941713e-03 | 2.404 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.986153e-03 | 2.399 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.167929e-03 | 2.380 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.430109e-03 | 2.354 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.430109e-03 | 2.354 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.430109e-03 | 2.354 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.430109e-03 | 2.354 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.454457e-03 | 2.351 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.593095e-03 | 2.338 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.649528e-03 | 2.333 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.649528e-03 | 2.333 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.687000e-03 | 2.329 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.702513e-03 | 2.328 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.781501e-03 | 2.320 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.804929e-03 | 2.318 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.849515e-03 | 2.314 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.926696e-03 | 2.307 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.969048e-03 | 2.304 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.969048e-03 | 2.304 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.005410e-03 | 2.301 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.062961e-03 | 2.296 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.761935e-03 | 2.239 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.954325e-03 | 2.225 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.675951e-03 | 2.246 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.452884e-03 | 2.263 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.675951e-03 | 2.246 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.338006e-03 | 2.198 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.338006e-03 | 2.198 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.338006e-03 | 2.198 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.310904e-03 | 2.200 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.260461e-03 | 2.203 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.353815e-03 | 2.197 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.353815e-03 | 2.197 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.357797e-03 | 2.197 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.608987e-03 | 2.180 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.701406e-03 | 2.174 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.782674e-03 | 2.169 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.880673e-03 | 2.162 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.880673e-03 | 2.162 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.938301e-03 | 2.159 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.938301e-03 | 2.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.938301e-03 | 2.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.938301e-03 | 2.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.938301e-03 | 2.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.938301e-03 | 2.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.938301e-03 | 2.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.938301e-03 | 2.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.938301e-03 | 2.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.938301e-03 | 2.159 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.938301e-03 | 2.159 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.259188e-03 | 2.139 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.259188e-03 | 2.139 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.259188e-03 | 2.139 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.259188e-03 | 2.139 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.293753e-03 | 2.137 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.367463e-03 | 2.133 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.492826e-03 | 2.125 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.682037e-03 | 2.115 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.682037e-03 | 2.115 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.703654e-03 | 2.113 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.026508e-03 | 2.044 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.026508e-03 | 2.044 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.624605e-03 | 2.017 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.026508e-03 | 2.044 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.451754e-03 | 2.073 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.281185e-03 | 2.082 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.686178e-03 | 2.061 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.281185e-03 | 2.082 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.624605e-03 | 2.017 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.387094e-03 | 2.027 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.826180e-03 | 2.008 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.281185e-03 | 2.082 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.624605e-03 | 2.017 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.624605e-03 | 2.017 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.712227e-03 | 2.060 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.721274e-03 | 2.012 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.657917e-03 | 2.063 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.020723e-02 | 1.991 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.033197e-02 | 1.986 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.059010e-02 | 1.975 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.059010e-02 | 1.975 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.059010e-02 | 1.975 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.076571e-02 | 1.968 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.084395e-02 | 1.965 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.087593e-02 | 1.964 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.104828e-02 | 1.957 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.109007e-02 | 1.955 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.109007e-02 | 1.955 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.117607e-02 | 1.952 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.132428e-02 | 1.946 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.142915e-02 | 1.942 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.142938e-02 | 1.942 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.171212e-02 | 1.931 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.175317e-02 | 1.930 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.201985e-02 | 1.920 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.208952e-02 | 1.918 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.216862e-02 | 1.915 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.221925e-02 | 1.913 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.224326e-02 | 1.912 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.253725e-02 | 1.902 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.332163e-02 | 1.875 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.347556e-02 | 1.870 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.391962e-02 | 1.856 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.401180e-02 | 1.854 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.438263e-02 | 1.842 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.438263e-02 | 1.842 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.444843e-02 | 1.840 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.458695e-02 | 1.836 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.501725e-02 | 1.823 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.599306e-02 | 1.796 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.599306e-02 | 1.796 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.618417e-02 | 1.791 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.618417e-02 | 1.791 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.537613e-02 | 1.813 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.537613e-02 | 1.813 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.967720e-02 | 1.706 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.967720e-02 | 1.706 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.967720e-02 | 1.706 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.967720e-02 | 1.706 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.967720e-02 | 1.706 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.019063e-02 | 1.695 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.019063e-02 | 1.695 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.620789e-02 | 1.790 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.620789e-02 | 1.790 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.620789e-02 | 1.790 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.931083e-02 | 1.714 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.521285e-02 | 1.818 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.521285e-02 | 1.818 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.521285e-02 | 1.818 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.611162e-02 | 1.793 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.642355e-02 | 1.785 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.715140e-02 | 1.766 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.867137e-02 | 1.729 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.854639e-02 | 1.732 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.854639e-02 | 1.732 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.537613e-02 | 1.813 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.651092e-02 | 1.782 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.967720e-02 | 1.706 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.782054e-02 | 1.749 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.901439e-02 | 1.721 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.620789e-02 | 1.790 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.669077e-02 | 1.778 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.618417e-02 | 1.791 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.967720e-02 | 1.706 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.967720e-02 | 1.706 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.535106e-02 | 1.814 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.521285e-02 | 1.818 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.931083e-02 | 1.714 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.949991e-02 | 1.710 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.019063e-02 | 1.695 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.782151e-02 | 1.749 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.620789e-02 | 1.790 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.785686e-02 | 1.748 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.035777e-02 | 1.691 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.037547e-02 | 1.691 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.037547e-02 | 1.691 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.037547e-02 | 1.691 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.064519e-02 | 1.685 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.064519e-02 | 1.685 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.073403e-02 | 1.683 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.073403e-02 | 1.683 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.073403e-02 | 1.683 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.073403e-02 | 1.683 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.102560e-02 | 1.677 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.102560e-02 | 1.677 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.123765e-02 | 1.673 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.123765e-02 | 1.673 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.202057e-02 | 1.657 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.202057e-02 | 1.657 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.212337e-02 | 1.655 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.230994e-02 | 1.652 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.235475e-02 | 1.651 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.270396e-02 | 1.644 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.280681e-02 | 1.642 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.319156e-02 | 1.635 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.391301e-02 | 1.621 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.397010e-02 | 1.620 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.419862e-02 | 1.616 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.419862e-02 | 1.616 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.439049e-02 | 1.613 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.439049e-02 | 1.613 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.469894e-02 | 1.607 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.469894e-02 | 1.607 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.474067e-02 | 1.607 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.574239e-02 | 1.589 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.583515e-02 | 1.588 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.617244e-02 | 1.582 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.676555e-02 | 1.572 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.709962e-02 | 1.567 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.744192e-02 | 1.562 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.754453e-02 | 1.560 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.769901e-02 | 1.558 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.801334e-02 | 1.553 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.857309e-02 | 1.544 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.899165e-02 | 1.538 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.899165e-02 | 1.538 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.913691e-02 | 1.536 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.938537e-02 | 1.532 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.957035e-02 | 1.529 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.994852e-02 | 1.524 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.994852e-02 | 1.524 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.994852e-02 | 1.524 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.047656e-02 | 1.516 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.047656e-02 | 1.516 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.090472e-02 | 1.510 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.097947e-02 | 1.509 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.124122e-02 | 1.505 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.124122e-02 | 1.505 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.162805e-02 | 1.500 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.206507e-02 | 1.494 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.336154e-02 | 1.477 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.336367e-02 | 1.477 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.381586e-02 | 1.471 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.381586e-02 | 1.471 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.381586e-02 | 1.471 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 3.445265e-02 | 1.463 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.482238e-02 | 1.458 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.482565e-02 | 1.458 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.576593e-02 | 1.447 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.576593e-02 | 1.447 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.576593e-02 | 1.447 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.585132e-02 | 1.445 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.703755e-02 | 1.431 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.703755e-02 | 1.431 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.703755e-02 | 1.431 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.703755e-02 | 1.431 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.713097e-02 | 1.430 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.713097e-02 | 1.430 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.799840e-02 | 1.420 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.834058e-02 | 1.416 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.846412e-02 | 1.415 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.898089e-02 | 1.409 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.898089e-02 | 1.409 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 5.652355e-02 | 1.248 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.652355e-02 | 1.248 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 5.652355e-02 | 1.248 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 5.652355e-02 | 1.248 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 5.652355e-02 | 1.248 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.208664e-02 | 1.376 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 4.208664e-02 | 1.376 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.645330e-02 | 1.333 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.645330e-02 | 1.333 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.645330e-02 | 1.333 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.645330e-02 | 1.333 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.645330e-02 | 1.333 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.440149e-02 | 1.353 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.440149e-02 | 1.353 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.258008e-02 | 1.279 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.258008e-02 | 1.279 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.258008e-02 | 1.279 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.043837e-02 | 1.393 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.682471e-02 | 1.245 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.343762e-02 | 1.272 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.640537e-02 | 1.333 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.064806e-02 | 1.295 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.398416e-02 | 1.268 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.978532e-02 | 1.400 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.649754e-02 | 1.333 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.398416e-02 | 1.268 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.343762e-02 | 1.272 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.640537e-02 | 1.333 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.684073e-02 | 1.329 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.095955e-02 | 1.293 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.440149e-02 | 1.353 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.466681e-02 | 1.350 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.549990e-02 | 1.342 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.549990e-02 | 1.342 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.398416e-02 | 1.268 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.893501e-02 | 1.310 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.893501e-02 | 1.310 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.208664e-02 | 1.376 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.990991e-02 | 1.302 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.535193e-02 | 1.343 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.235887e-02 | 1.373 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.549990e-02 | 1.342 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.239511e-02 | 1.281 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.404618e-02 | 1.267 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.928067e-02 | 1.406 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.695599e-02 | 1.244 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.695599e-02 | 1.244 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.978532e-02 | 1.400 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.682372e-02 | 1.330 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.440149e-02 | 1.353 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.640537e-02 | 1.333 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.885194e-02 | 1.230 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.640537e-02 | 1.333 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.686352e-02 | 1.329 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.721045e-02 | 1.243 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.398416e-02 | 1.268 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.387961e-02 | 1.269 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.046534e-02 | 1.297 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.110775e-02 | 1.386 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.110775e-02 | 1.386 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.070763e-02 | 1.295 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.258008e-02 | 1.279 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.695599e-02 | 1.244 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.876721e-02 | 1.231 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.473927e-02 | 1.349 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.261715e-02 | 1.370 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.786031e-02 | 1.320 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.892748e-02 | 1.230 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.892748e-02 | 1.230 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.894073e-02 | 1.230 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.971480e-02 | 1.224 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.974289e-02 | 1.224 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.977317e-02 | 1.223 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.075226e-02 | 1.216 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.075226e-02 | 1.216 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.157736e-02 | 1.211 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.157736e-02 | 1.211 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.157736e-02 | 1.211 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.158355e-02 | 1.211 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.172499e-02 | 1.210 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.172499e-02 | 1.210 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.203713e-02 | 1.207 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.290071e-02 | 1.201 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.433763e-02 | 1.192 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.448075e-02 | 1.191 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.461426e-02 | 1.190 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.537927e-02 | 1.185 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.698467e-02 | 1.174 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.698467e-02 | 1.174 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.698467e-02 | 1.174 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.698467e-02 | 1.174 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.862062e-02 | 1.164 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.862062e-02 | 1.164 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.862062e-02 | 1.164 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.862062e-02 | 1.164 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.862062e-02 | 1.164 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.862062e-02 | 1.164 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.862062e-02 | 1.164 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.862062e-02 | 1.164 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.862062e-02 | 1.164 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.930614e-02 | 1.159 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.008833e-02 | 1.154 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.008833e-02 | 1.154 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.008833e-02 | 1.154 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.056781e-02 | 1.151 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.101733e-02 | 1.149 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.114841e-02 | 1.148 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.114841e-02 | 1.148 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 7.138990e-02 | 1.146 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.173863e-02 | 1.144 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.173863e-02 | 1.144 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.173863e-02 | 1.144 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 7.173863e-02 | 1.144 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.173863e-02 | 1.144 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.173863e-02 | 1.144 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.297320e-02 | 1.137 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.469676e-02 | 1.127 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.530812e-02 | 1.123 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.564221e-02 | 1.121 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.668948e-02 | 1.115 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.690184e-02 | 1.114 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.722874e-02 | 1.112 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.757007e-02 | 1.110 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.757007e-02 | 1.110 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.757007e-02 | 1.110 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.907242e-02 | 1.102 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.907242e-02 | 1.102 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.907242e-02 | 1.102 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.024719e-02 | 1.096 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.043221e-02 | 1.095 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.141473e-02 | 1.089 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.141473e-02 | 1.089 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.200728e-02 | 1.086 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.290902e-02 | 1.081 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.290902e-02 | 1.081 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 8.290902e-02 | 1.081 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 8.308236e-02 | 1.080 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 8.308236e-02 | 1.080 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 8.308236e-02 | 1.080 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 8.308236e-02 | 1.080 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 8.308236e-02 | 1.080 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.315926e-02 | 1.080 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.362178e-02 | 1.078 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.449442e-02 | 1.073 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.712782e-02 | 1.060 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 8.867155e-02 | 1.052 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 8.925308e-02 | 1.049 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 8.925308e-02 | 1.049 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.925308e-02 | 1.049 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.032811e-02 | 1.044 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.086775e-02 | 1.042 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.086775e-02 | 1.042 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 9.161853e-02 | 1.038 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.161853e-02 | 1.038 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.199982e-02 | 1.036 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.237283e-02 | 1.034 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.237283e-02 | 1.034 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.237283e-02 | 1.034 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.238524e-02 | 1.034 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.341252e-02 | 1.030 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.341252e-02 | 1.030 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 9.341252e-02 | 1.030 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 9.341252e-02 | 1.030 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 9.341252e-02 | 1.030 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 9.341252e-02 | 1.030 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.341252e-02 | 1.030 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.341252e-02 | 1.030 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.341252e-02 | 1.030 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.341252e-02 | 1.030 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.453992e-02 | 1.024 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.453992e-02 | 1.024 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.453992e-02 | 1.024 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.529368e-02 | 1.021 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.825096e-02 | 1.008 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.887622e-02 | 1.005 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.008199e-01 | 0.996 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.008199e-01 | 0.996 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.008199e-01 | 0.996 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.008199e-01 | 0.996 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.011059e-01 | 0.995 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.026706e-01 | 0.989 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.734834e-01 | 0.761 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.734834e-01 | 0.761 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.734834e-01 | 0.761 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.734834e-01 | 0.761 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.734834e-01 | 0.761 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.734834e-01 | 0.761 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.734834e-01 | 0.761 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.734834e-01 | 0.761 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.734834e-01 | 0.761 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.734834e-01 | 0.761 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 1.734834e-01 | 0.761 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.734834e-01 | 0.761 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.126058e-01 | 0.948 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.126058e-01 | 0.948 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.126058e-01 | 0.948 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.126058e-01 | 0.948 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.443367e-01 | 0.841 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.443367e-01 | 0.841 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.443367e-01 | 0.841 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.443367e-01 | 0.841 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.083559e-01 | 0.965 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.083559e-01 | 0.965 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 1.083559e-01 | 0.965 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.083559e-01 | 0.965 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 1.776306e-01 | 0.750 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.776306e-01 | 0.750 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.776306e-01 | 0.750 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.776306e-01 | 0.750 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.288772e-01 | 0.890 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.288772e-01 | 0.890 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.288772e-01 | 0.890 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 1.102025e-01 | 0.958 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 1.260775e-01 | 0.899 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.260775e-01 | 0.899 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.428484e-01 | 0.845 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.428484e-01 | 0.845 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.320988e-01 | 0.879 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 1.787713e-01 | 0.748 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.210464e-01 | 0.917 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.329759e-01 | 0.876 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 1.767541e-01 | 0.753 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 1.767541e-01 | 0.753 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 1.767541e-01 | 0.753 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.767541e-01 | 0.753 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.244415e-01 | 0.905 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.244415e-01 | 0.905 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.046070e-01 | 0.689 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.991011e-01 | 0.701 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.423549e-01 | 0.847 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 1.734701e-01 | 0.761 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.329759e-01 | 0.876 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.927683e-01 | 0.715 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.381832e-01 | 0.860 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 1.847290e-01 | 0.733 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.787713e-01 | 0.748 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.944754e-01 | 0.711 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.857734e-01 | 0.731 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.102025e-01 | 0.958 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 1.055826e-01 | 0.976 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 1.927683e-01 | 0.715 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.718664e-01 | 0.765 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.094975e-01 | 0.961 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.443367e-01 | 0.841 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.288772e-01 | 0.890 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.105053e-01 | 0.957 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.718664e-01 | 0.765 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.394483e-01 | 0.856 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.394483e-01 | 0.856 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.206647e-01 | 0.918 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.206647e-01 | 0.918 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.718664e-01 | 0.765 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.907593e-01 | 0.720 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.734701e-01 | 0.761 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 1.055826e-01 | 0.976 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.977620e-01 | 0.704 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.454394e-01 | 0.837 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.840106e-01 | 0.735 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.816098e-01 | 0.741 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.381832e-01 | 0.860 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.054147e-01 | 0.687 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.054147e-01 | 0.687 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.054147e-01 | 0.687 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.054147e-01 | 0.687 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.288772e-01 | 0.890 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.734834e-01 | 0.761 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.083559e-01 | 0.965 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 1.506411e-01 | 0.822 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.734701e-01 | 0.761 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.428484e-01 | 0.845 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.718664e-01 | 0.765 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.780775e-01 | 0.749 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.787713e-01 | 0.748 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.612739e-01 | 0.792 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.612739e-01 | 0.792 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.115009e-01 | 0.953 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.584120e-01 | 0.800 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.454394e-01 | 0.837 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.829792e-01 | 0.738 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 1.977620e-01 | 0.704 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.907593e-01 | 0.720 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.907593e-01 | 0.720 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.920339e-01 | 0.717 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.105053e-01 | 0.957 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.463741e-01 | 0.835 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.210464e-01 | 0.917 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.218814e-01 | 0.914 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.184891e-01 | 0.926 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.907593e-01 | 0.720 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.478206e-01 | 0.830 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.001023e-01 | 0.699 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.977620e-01 | 0.704 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 1.971890e-01 | 0.705 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.313359e-01 | 0.882 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.734834e-01 | 0.761 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.734834e-01 | 0.761 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.126058e-01 | 0.948 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 1.443367e-01 | 0.841 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 1.083559e-01 | 0.965 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.083559e-01 | 0.965 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 1.776306e-01 | 0.750 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.260775e-01 | 0.899 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.971890e-01 | 0.705 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 1.787713e-01 | 0.748 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.312860e-01 | 0.882 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.282323e-01 | 0.892 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.657693e-01 | 0.780 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.001023e-01 | 0.699 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.591979e-01 | 0.798 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.370587e-01 | 0.863 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.037925e-01 | 0.691 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.054147e-01 | 0.687 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.049372e-01 | 0.979 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.409430e-01 | 0.851 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.308805e-01 | 0.883 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.633153e-01 | 0.787 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.816098e-01 | 0.741 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.816098e-01 | 0.741 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.584120e-01 | 0.800 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.857734e-01 | 0.731 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.485090e-01 | 0.828 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.001023e-01 | 0.699 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.052990e-01 | 0.688 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.054147e-01 | 0.687 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.419247e-01 | 0.848 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.001023e-01 | 0.699 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.927683e-01 | 0.715 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.083559e-01 | 0.965 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.767541e-01 | 0.753 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.184891e-01 | 0.926 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.381832e-01 | 0.860 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.381832e-01 | 0.860 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.288772e-01 | 0.890 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.313359e-01 | 0.882 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.485090e-01 | 0.828 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.801672e-01 | 0.744 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.313359e-01 | 0.882 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.776306e-01 | 0.750 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.718664e-01 | 0.765 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.942742e-01 | 0.712 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.942742e-01 | 0.712 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.329759e-01 | 0.876 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.478206e-01 | 0.830 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.055826e-01 | 0.976 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.767541e-01 | 0.753 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.702363e-01 | 0.769 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.005110e-01 | 0.698 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 1.288772e-01 | 0.890 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.055826e-01 | 0.976 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.463741e-01 | 0.835 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 1.702363e-01 | 0.769 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.047517e-01 | 0.980 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.857734e-01 | 0.731 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.443367e-01 | 0.841 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.538552e-01 | 0.813 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.657693e-01 | 0.780 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.780775e-01 | 0.749 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.343894e-01 | 0.872 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 1.744400e-01 | 0.758 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.394483e-01 | 0.856 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.288772e-01 | 0.890 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.776306e-01 | 0.750 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.428484e-01 | 0.845 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.787713e-01 | 0.748 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.282323e-01 | 0.892 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.001023e-01 | 0.699 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.260775e-01 | 0.899 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.604395e-01 | 0.795 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.080584e-01 | 0.682 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.092680e-01 | 0.679 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.092680e-01 | 0.679 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.092680e-01 | 0.679 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.092680e-01 | 0.679 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.119419e-01 | 0.674 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.119419e-01 | 0.674 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.119419e-01 | 0.674 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.119419e-01 | 0.674 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.119419e-01 | 0.674 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.119419e-01 | 0.674 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.119419e-01 | 0.674 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.119419e-01 | 0.674 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.119419e-01 | 0.674 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 2.119419e-01 | 0.674 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.119419e-01 | 0.674 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.131700e-01 | 0.671 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.148208e-01 | 0.668 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.148208e-01 | 0.668 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.148208e-01 | 0.668 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.148208e-01 | 0.668 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.152908e-01 | 0.667 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.152908e-01 | 0.667 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.165485e-01 | 0.664 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.168093e-01 | 0.664 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.171541e-01 | 0.663 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.171541e-01 | 0.663 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.173284e-01 | 0.663 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.173284e-01 | 0.663 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.173284e-01 | 0.663 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.175807e-01 | 0.662 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.216276e-01 | 0.654 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.216276e-01 | 0.654 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.216276e-01 | 0.654 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 2.216276e-01 | 0.654 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.216276e-01 | 0.654 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.216276e-01 | 0.654 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.262036e-01 | 0.646 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.272796e-01 | 0.643 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.298955e-01 | 0.638 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.308200e-01 | 0.637 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.308200e-01 | 0.637 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.373874e-01 | 0.625 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.373874e-01 | 0.625 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.373874e-01 | 0.625 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.373874e-01 | 0.625 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.401662e-01 | 0.619 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.403033e-01 | 0.619 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 2.408603e-01 | 0.618 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.414315e-01 | 0.617 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.429280e-01 | 0.615 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.435247e-01 | 0.613 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.435885e-01 | 0.613 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.447655e-01 | 0.611 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.447655e-01 | 0.611 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.447655e-01 | 0.611 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.447655e-01 | 0.611 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.447655e-01 | 0.611 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.447655e-01 | 0.611 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.452923e-01 | 0.610 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.452923e-01 | 0.610 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.452923e-01 | 0.610 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.466230e-01 | 0.608 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.466230e-01 | 0.608 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.466230e-01 | 0.608 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.466230e-01 | 0.608 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.466230e-01 | 0.608 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.466230e-01 | 0.608 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 2.466230e-01 | 0.608 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.468113e-01 | 0.608 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.468113e-01 | 0.608 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.468113e-01 | 0.608 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.468113e-01 | 0.608 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.468113e-01 | 0.608 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.468113e-01 | 0.608 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.468113e-01 | 0.608 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.468113e-01 | 0.608 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 2.468113e-01 | 0.608 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.468113e-01 | 0.608 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.468113e-01 | 0.608 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.485960e-01 | 0.605 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.485960e-01 | 0.605 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.485960e-01 | 0.605 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.485960e-01 | 0.605 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.485960e-01 | 0.605 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.485960e-01 | 0.605 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.485960e-01 | 0.605 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 2.485960e-01 | 0.605 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.485960e-01 | 0.605 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.485960e-01 | 0.605 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.485960e-01 | 0.605 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.485960e-01 | 0.605 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.485960e-01 | 0.605 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.485960e-01 | 0.605 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.485960e-01 | 0.605 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.501352e-01 | 0.602 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.523730e-01 | 0.598 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.578565e-01 | 0.589 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.578565e-01 | 0.589 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.586204e-01 | 0.587 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.589653e-01 | 0.587 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 2.589653e-01 | 0.587 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.595421e-01 | 0.586 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.609764e-01 | 0.583 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.611804e-01 | 0.583 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.611804e-01 | 0.583 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 2.611804e-01 | 0.583 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.662363e-01 | 0.575 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.662363e-01 | 0.575 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.662363e-01 | 0.575 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.691929e-01 | 0.570 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.691929e-01 | 0.570 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.720209e-01 | 0.565 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.720209e-01 | 0.565 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.720209e-01 | 0.565 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.720209e-01 | 0.565 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.720209e-01 | 0.565 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 2.720209e-01 | 0.565 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.733936e-01 | 0.563 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.769130e-01 | 0.558 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.769130e-01 | 0.558 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.769130e-01 | 0.558 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.786549e-01 | 0.555 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.787250e-01 | 0.555 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 2.818543e-01 | 0.550 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 2.818543e-01 | 0.550 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 2.818543e-01 | 0.550 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.818543e-01 | 0.550 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.818543e-01 | 0.550 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.880246e-01 | 0.541 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.880246e-01 | 0.541 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.895804e-01 | 0.538 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.910874e-01 | 0.536 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.930668e-01 | 0.533 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.972938e-01 | 0.527 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 2.972938e-01 | 0.527 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.976772e-01 | 0.526 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.976772e-01 | 0.526 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.976772e-01 | 0.526 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.976772e-01 | 0.526 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.997039e-01 | 0.523 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.997039e-01 | 0.523 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.997039e-01 | 0.523 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.024361e-01 | 0.519 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.028320e-01 | 0.519 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.072560e-01 | 0.512 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.094029e-01 | 0.509 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.094029e-01 | 0.509 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.156517e-01 | 0.501 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.156517e-01 | 0.501 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 3.167517e-01 | 0.499 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.167517e-01 | 0.499 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.167517e-01 | 0.499 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.167517e-01 | 0.499 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.167517e-01 | 0.499 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.167517e-01 | 0.499 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.167517e-01 | 0.499 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.168866e-01 | 0.499 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.168866e-01 | 0.499 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.168866e-01 | 0.499 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.168866e-01 | 0.499 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.168866e-01 | 0.499 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.168866e-01 | 0.499 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.168866e-01 | 0.499 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.209281e-01 | 0.494 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 3.209281e-01 | 0.494 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.209281e-01 | 0.494 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.233170e-01 | 0.490 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.234581e-01 | 0.490 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.234581e-01 | 0.490 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.234581e-01 | 0.490 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.234581e-01 | 0.490 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.250617e-01 | 0.488 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.258866e-01 | 0.487 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.328719e-01 | 0.478 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.341459e-01 | 0.476 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.378196e-01 | 0.471 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.422549e-01 | 0.466 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.422549e-01 | 0.466 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 3.424840e-01 | 0.465 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 3.424840e-01 | 0.465 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.424840e-01 | 0.465 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 3.459388e-01 | 0.461 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.473277e-01 | 0.459 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.473277e-01 | 0.459 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.473277e-01 | 0.459 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.480528e-01 | 0.458 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.480528e-01 | 0.458 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.480528e-01 | 0.458 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.492409e-01 | 0.457 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.492409e-01 | 0.457 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.492409e-01 | 0.457 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.512407e-01 | 0.454 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.512407e-01 | 0.454 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.512407e-01 | 0.454 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.512407e-01 | 0.454 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.512407e-01 | 0.454 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.512407e-01 | 0.454 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.512407e-01 | 0.454 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.561670e-01 | 0.448 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.585625e-01 | 0.445 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 3.624979e-01 | 0.441 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.633070e-01 | 0.440 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.636157e-01 | 0.439 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.636157e-01 | 0.439 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.636157e-01 | 0.439 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.636157e-01 | 0.439 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.660294e-01 | 0.436 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.696786e-01 | 0.432 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.749140e-01 | 0.426 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.749140e-01 | 0.426 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.749140e-01 | 0.426 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.789742e-01 | 0.421 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.789742e-01 | 0.421 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 3.789742e-01 | 0.421 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.789742e-01 | 0.421 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.789742e-01 | 0.421 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 3.789742e-01 | 0.421 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 3.789742e-01 | 0.421 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.789742e-01 | 0.421 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.789742e-01 | 0.421 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 3.849458e-01 | 0.415 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.851074e-01 | 0.414 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.851074e-01 | 0.414 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.899860e-01 | 0.409 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.899860e-01 | 0.409 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.926282e-01 | 0.406 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.926282e-01 | 0.406 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.939369e-01 | 0.405 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.940122e-01 | 0.404 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.003769e-01 | 0.398 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.003769e-01 | 0.398 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.003769e-01 | 0.398 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.003769e-01 | 0.398 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.003769e-01 | 0.398 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.061848e-01 | 0.391 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.061848e-01 | 0.391 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.061848e-01 | 0.391 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.077305e-01 | 0.390 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.092646e-01 | 0.388 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.181802e-01 | 0.379 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.181802e-01 | 0.379 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.181802e-01 | 0.379 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.181802e-01 | 0.379 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.191807e-01 | 0.378 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.210603e-01 | 0.376 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.245701e-01 | 0.372 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.255396e-01 | 0.371 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.255396e-01 | 0.371 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.260387e-01 | 0.371 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.272763e-01 | 0.369 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.272763e-01 | 0.369 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.272763e-01 | 0.369 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 4.272763e-01 | 0.369 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.311183e-01 | 0.365 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.343756e-01 | 0.362 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.354222e-01 | 0.361 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.354222e-01 | 0.361 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.354222e-01 | 0.361 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.354222e-01 | 0.361 | 0 | 0 |
| Defective FMO3 causes TMAU | R-HSA-5579019 | 4.354222e-01 | 0.361 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.354222e-01 | 0.361 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.354222e-01 | 0.361 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.354222e-01 | 0.361 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.354222e-01 | 0.361 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.354222e-01 | 0.361 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.354222e-01 | 0.361 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.354222e-01 | 0.361 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.367223e-01 | 0.360 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.454748e-01 | 0.351 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.454748e-01 | 0.351 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.462418e-01 | 0.350 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.462418e-01 | 0.350 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.469268e-01 | 0.350 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.471433e-01 | 0.350 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.476619e-01 | 0.349 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.481686e-01 | 0.349 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.481686e-01 | 0.349 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.503228e-01 | 0.346 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.503238e-01 | 0.346 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.503238e-01 | 0.346 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.503238e-01 | 0.346 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.503238e-01 | 0.346 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.503238e-01 | 0.346 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.503238e-01 | 0.346 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.503238e-01 | 0.346 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.503238e-01 | 0.346 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.503238e-01 | 0.346 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.503238e-01 | 0.346 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.503238e-01 | 0.346 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.503238e-01 | 0.346 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.503238e-01 | 0.346 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 4.568593e-01 | 0.340 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.603466e-01 | 0.337 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.688142e-01 | 0.329 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.722829e-01 | 0.326 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.740056e-01 | 0.324 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.746570e-01 | 0.324 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.755544e-01 | 0.323 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.814339e-01 | 0.317 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.814339e-01 | 0.317 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.814339e-01 | 0.317 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.814339e-01 | 0.317 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 4.817727e-01 | 0.317 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.817727e-01 | 0.317 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.835833e-01 | 0.316 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.851411e-01 | 0.314 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.851411e-01 | 0.314 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.851411e-01 | 0.314 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.867423e-01 | 0.313 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 4.867423e-01 | 0.313 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.867423e-01 | 0.313 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.867423e-01 | 0.313 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.867423e-01 | 0.313 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.867423e-01 | 0.313 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.867423e-01 | 0.313 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.867423e-01 | 0.313 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.867423e-01 | 0.313 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.867423e-01 | 0.313 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.867423e-01 | 0.313 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.867423e-01 | 0.313 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.867423e-01 | 0.313 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.867423e-01 | 0.313 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.917975e-01 | 0.308 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.932252e-01 | 0.307 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.984821e-01 | 0.302 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.984821e-01 | 0.302 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 4.984821e-01 | 0.302 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.984821e-01 | 0.302 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.984821e-01 | 0.302 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.984821e-01 | 0.302 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 4.996164e-01 | 0.301 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.000219e-01 | 0.301 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.003832e-01 | 0.301 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.070345e-01 | 0.295 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.091969e-01 | 0.293 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.091969e-01 | 0.293 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.091969e-01 | 0.293 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.091969e-01 | 0.293 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.091969e-01 | 0.293 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.114328e-01 | 0.291 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.114328e-01 | 0.291 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.114328e-01 | 0.291 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 5.114328e-01 | 0.291 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.114328e-01 | 0.291 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.171595e-01 | 0.286 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.204604e-01 | 0.284 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.207226e-01 | 0.283 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 5.217472e-01 | 0.283 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.237545e-01 | 0.281 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.237545e-01 | 0.281 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.282168e-01 | 0.277 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.288606e-01 | 0.277 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.293442e-01 | 0.276 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.293442e-01 | 0.276 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.334002e-01 | 0.273 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.334002e-01 | 0.273 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.334002e-01 | 0.273 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.334002e-01 | 0.273 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.334002e-01 | 0.273 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.334002e-01 | 0.273 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.334002e-01 | 0.273 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.334002e-01 | 0.273 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.334002e-01 | 0.273 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.334002e-01 | 0.273 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.334002e-01 | 0.273 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.334002e-01 | 0.273 | 0 | 0 |
| Intestinal hexose absorption | R-HSA-8981373 | 5.334002e-01 | 0.273 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.334002e-01 | 0.273 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.334002e-01 | 0.273 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.334002e-01 | 0.273 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.334002e-01 | 0.273 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.334002e-01 | 0.273 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.342760e-01 | 0.272 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.402656e-01 | 0.267 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.402656e-01 | 0.267 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.402656e-01 | 0.267 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.402656e-01 | 0.267 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.402656e-01 | 0.267 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.402656e-01 | 0.267 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.402656e-01 | 0.267 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.437539e-01 | 0.265 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.437539e-01 | 0.265 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.444091e-01 | 0.264 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.444091e-01 | 0.264 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 5.444091e-01 | 0.264 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.481303e-01 | 0.261 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.516027e-01 | 0.258 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.664329e-01 | 0.247 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.664329e-01 | 0.247 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.664329e-01 | 0.247 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 5.664329e-01 | 0.247 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 5.664602e-01 | 0.247 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.669793e-01 | 0.246 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.669793e-01 | 0.246 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.669793e-01 | 0.246 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.678963e-01 | 0.246 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 5.678963e-01 | 0.246 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.678963e-01 | 0.246 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.678963e-01 | 0.246 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.678963e-01 | 0.246 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.678963e-01 | 0.246 | 0 | 0 |
| Mineralocorticoid biosynthesis | R-HSA-193993 | 5.678963e-01 | 0.246 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.678963e-01 | 0.246 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.758192e-01 | 0.240 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.758192e-01 | 0.240 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 5.758192e-01 | 0.240 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.758192e-01 | 0.240 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.758192e-01 | 0.240 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.758192e-01 | 0.240 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.758192e-01 | 0.240 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.853846e-01 | 0.233 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.853846e-01 | 0.233 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.853846e-01 | 0.233 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.877902e-01 | 0.231 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.877902e-01 | 0.231 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.911003e-01 | 0.228 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.943053e-01 | 0.226 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 5.943053e-01 | 0.226 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 5.943053e-01 | 0.226 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 5.943053e-01 | 0.226 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.033266e-01 | 0.219 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.084594e-01 | 0.216 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.084594e-01 | 0.216 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.084594e-01 | 0.216 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.084594e-01 | 0.216 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.140854e-01 | 0.212 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.143841e-01 | 0.212 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.143841e-01 | 0.212 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.143841e-01 | 0.212 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.143841e-01 | 0.212 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.143841e-01 | 0.212 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.143841e-01 | 0.212 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.143841e-01 | 0.212 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.143841e-01 | 0.212 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.143841e-01 | 0.212 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.168272e-01 | 0.210 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.194862e-01 | 0.208 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.194862e-01 | 0.208 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.194862e-01 | 0.208 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.194862e-01 | 0.208 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.194862e-01 | 0.208 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.194862e-01 | 0.208 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.263916e-01 | 0.203 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 6.281807e-01 | 0.202 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.284246e-01 | 0.202 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.284246e-01 | 0.202 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.334947e-01 | 0.198 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.334947e-01 | 0.198 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.334947e-01 | 0.198 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.350441e-01 | 0.197 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.377594e-01 | 0.195 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.427882e-01 | 0.192 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.434441e-01 | 0.191 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.434441e-01 | 0.191 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.434441e-01 | 0.191 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.434441e-01 | 0.191 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.434441e-01 | 0.191 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.462935e-01 | 0.190 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.476755e-01 | 0.189 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.494449e-01 | 0.187 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.494449e-01 | 0.187 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.494449e-01 | 0.187 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.494449e-01 | 0.187 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.494449e-01 | 0.187 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.494449e-01 | 0.187 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.494449e-01 | 0.187 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.494449e-01 | 0.187 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.494449e-01 | 0.187 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.494449e-01 | 0.187 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 6.494449e-01 | 0.187 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.494449e-01 | 0.187 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 6.494449e-01 | 0.187 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.494449e-01 | 0.187 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.494449e-01 | 0.187 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.494449e-01 | 0.187 | 0 | 0 |
| Intestinal absorption | R-HSA-8963676 | 6.494449e-01 | 0.187 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.494449e-01 | 0.187 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 6.513160e-01 | 0.186 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.542271e-01 | 0.184 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.542271e-01 | 0.184 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.542271e-01 | 0.184 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.542271e-01 | 0.184 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.554534e-01 | 0.183 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.554534e-01 | 0.183 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 6.600180e-01 | 0.180 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.636515e-01 | 0.178 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.661932e-01 | 0.176 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.661932e-01 | 0.176 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.662062e-01 | 0.176 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.701849e-01 | 0.174 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.755602e-01 | 0.170 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.813198e-01 | 0.167 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.813198e-01 | 0.167 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.813198e-01 | 0.167 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.813198e-01 | 0.167 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.813198e-01 | 0.167 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 6.813198e-01 | 0.167 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.813198e-01 | 0.167 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.813198e-01 | 0.167 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.813198e-01 | 0.167 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.813198e-01 | 0.167 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.813198e-01 | 0.167 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.813198e-01 | 0.167 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.813198e-01 | 0.167 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.813198e-01 | 0.167 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.856279e-01 | 0.164 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 6.856279e-01 | 0.164 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.877551e-01 | 0.163 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 6.877551e-01 | 0.163 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 6.886483e-01 | 0.162 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.892794e-01 | 0.162 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 6.893335e-01 | 0.162 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.990200e-01 | 0.156 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.005537e-01 | 0.155 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.019133e-01 | 0.154 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.081578e-01 | 0.150 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.081578e-01 | 0.150 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.081578e-01 | 0.150 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.081578e-01 | 0.150 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.102511e-01 | 0.149 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.102981e-01 | 0.149 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.102981e-01 | 0.149 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.102981e-01 | 0.149 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.102981e-01 | 0.149 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.102981e-01 | 0.149 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.102981e-01 | 0.149 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.102981e-01 | 0.149 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.102981e-01 | 0.149 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.102981e-01 | 0.149 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.102981e-01 | 0.149 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.199122e-01 | 0.143 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.199122e-01 | 0.143 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.270942e-01 | 0.138 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.274336e-01 | 0.138 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.274336e-01 | 0.138 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 7.274336e-01 | 0.138 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 7.274336e-01 | 0.138 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.274336e-01 | 0.138 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 7.274336e-01 | 0.138 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.288535e-01 | 0.137 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.288758e-01 | 0.137 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.331520e-01 | 0.135 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.331520e-01 | 0.135 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 7.331520e-01 | 0.135 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.366430e-01 | 0.133 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.366430e-01 | 0.133 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.366430e-01 | 0.133 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.366430e-01 | 0.133 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.366430e-01 | 0.133 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.366430e-01 | 0.133 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 7.366430e-01 | 0.133 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.366430e-01 | 0.133 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.366430e-01 | 0.133 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.366430e-01 | 0.133 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.366430e-01 | 0.133 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.366430e-01 | 0.133 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.366430e-01 | 0.133 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.455732e-01 | 0.128 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.455732e-01 | 0.128 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.456187e-01 | 0.127 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.456187e-01 | 0.127 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.456187e-01 | 0.127 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 7.456187e-01 | 0.127 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.456187e-01 | 0.127 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.481289e-01 | 0.126 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.521277e-01 | 0.124 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.521277e-01 | 0.124 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.540138e-01 | 0.123 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.540138e-01 | 0.123 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.551032e-01 | 0.122 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.605935e-01 | 0.119 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.605935e-01 | 0.119 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 7.605935e-01 | 0.119 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.605935e-01 | 0.119 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.605935e-01 | 0.119 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.605935e-01 | 0.119 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.605935e-01 | 0.119 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.605935e-01 | 0.119 | 0 | 0 |
| FMO oxidises nucleophiles | R-HSA-217271 | 7.605935e-01 | 0.119 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.605935e-01 | 0.119 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.605935e-01 | 0.119 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.605935e-01 | 0.119 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.615311e-01 | 0.118 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 7.624248e-01 | 0.118 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.627521e-01 | 0.118 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.627521e-01 | 0.118 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.627521e-01 | 0.118 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 7.627521e-01 | 0.118 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.634756e-01 | 0.117 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.634756e-01 | 0.117 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.744261e-01 | 0.111 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.744261e-01 | 0.111 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.788747e-01 | 0.109 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.788747e-01 | 0.109 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.788747e-01 | 0.109 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.823671e-01 | 0.107 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.823671e-01 | 0.107 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.823671e-01 | 0.107 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.823671e-01 | 0.107 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.823671e-01 | 0.107 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 7.823671e-01 | 0.107 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.823671e-01 | 0.107 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.823671e-01 | 0.107 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.849839e-01 | 0.105 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.890357e-01 | 0.103 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.940284e-01 | 0.100 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.940284e-01 | 0.100 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.940284e-01 | 0.100 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.940284e-01 | 0.100 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.951543e-01 | 0.100 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.951543e-01 | 0.100 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 7.985318e-01 | 0.098 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.013850e-01 | 0.096 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.013850e-01 | 0.096 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.016483e-01 | 0.096 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.021617e-01 | 0.096 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.021617e-01 | 0.096 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.021617e-01 | 0.096 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.021617e-01 | 0.096 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.021617e-01 | 0.096 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.021617e-01 | 0.096 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.021617e-01 | 0.096 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.082562e-01 | 0.092 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.082562e-01 | 0.092 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.082562e-01 | 0.092 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 8.082562e-01 | 0.092 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.082562e-01 | 0.092 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.082562e-01 | 0.092 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.131216e-01 | 0.090 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.131216e-01 | 0.090 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.131216e-01 | 0.090 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.131216e-01 | 0.090 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.132782e-01 | 0.090 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.132782e-01 | 0.090 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.199342e-01 | 0.086 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.201569e-01 | 0.086 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.201569e-01 | 0.086 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.201569e-01 | 0.086 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.201569e-01 | 0.086 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.201569e-01 | 0.086 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.201569e-01 | 0.086 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.201569e-01 | 0.086 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.208288e-01 | 0.086 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.216010e-01 | 0.085 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.216010e-01 | 0.085 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.216010e-01 | 0.085 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.216010e-01 | 0.085 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.242650e-01 | 0.084 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.242650e-01 | 0.084 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.242650e-01 | 0.084 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.242650e-01 | 0.084 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.242650e-01 | 0.084 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 8.264961e-01 | 0.083 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.341057e-01 | 0.079 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.341057e-01 | 0.079 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.365163e-01 | 0.078 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.365163e-01 | 0.078 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.365163e-01 | 0.078 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.365163e-01 | 0.078 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.365163e-01 | 0.078 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.418747e-01 | 0.075 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.448532e-01 | 0.073 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.448532e-01 | 0.073 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.464096e-01 | 0.072 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.513884e-01 | 0.070 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.513884e-01 | 0.070 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.513884e-01 | 0.070 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.513884e-01 | 0.070 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.513884e-01 | 0.070 | 0 | 0 |
| Carnitine synthesis | R-HSA-71262 | 8.513884e-01 | 0.070 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.513884e-01 | 0.070 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.513884e-01 | 0.070 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.543392e-01 | 0.068 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.567637e-01 | 0.067 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.567637e-01 | 0.067 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.633963e-01 | 0.064 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.647261e-01 | 0.063 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.647261e-01 | 0.063 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.649084e-01 | 0.063 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.649084e-01 | 0.063 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.649084e-01 | 0.063 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.649084e-01 | 0.063 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.649084e-01 | 0.063 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.649084e-01 | 0.063 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.669992e-01 | 0.062 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.669992e-01 | 0.062 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.683375e-01 | 0.061 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.717994e-01 | 0.060 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.730816e-01 | 0.059 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.730816e-01 | 0.059 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 8.749523e-01 | 0.058 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.765587e-01 | 0.057 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.765587e-01 | 0.057 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.765587e-01 | 0.057 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.771992e-01 | 0.057 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.771992e-01 | 0.057 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.771992e-01 | 0.057 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 8.771992e-01 | 0.057 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.771992e-01 | 0.057 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.798150e-01 | 0.056 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.803238e-01 | 0.055 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.854805e-01 | 0.053 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.873816e-01 | 0.052 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.883724e-01 | 0.051 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.883724e-01 | 0.051 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.883724e-01 | 0.051 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.883724e-01 | 0.051 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.883724e-01 | 0.051 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.938015e-01 | 0.049 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.938015e-01 | 0.049 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.963455e-01 | 0.048 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 8.985295e-01 | 0.046 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.985295e-01 | 0.046 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.985295e-01 | 0.046 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.985295e-01 | 0.046 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.985295e-01 | 0.046 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.985295e-01 | 0.046 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.985295e-01 | 0.046 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.015570e-01 | 0.045 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.015570e-01 | 0.045 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.041574e-01 | 0.044 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.041624e-01 | 0.044 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.077630e-01 | 0.042 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.077630e-01 | 0.042 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.077630e-01 | 0.042 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.135540e-01 | 0.039 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.155063e-01 | 0.038 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.155438e-01 | 0.038 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.161568e-01 | 0.038 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.161568e-01 | 0.038 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.161568e-01 | 0.038 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.161568e-01 | 0.038 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.161568e-01 | 0.038 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.165996e-01 | 0.038 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.165996e-01 | 0.038 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.191689e-01 | 0.037 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.205202e-01 | 0.036 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.237872e-01 | 0.034 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.237872e-01 | 0.034 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.237872e-01 | 0.034 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.237872e-01 | 0.034 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.259326e-01 | 0.033 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.259326e-01 | 0.033 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.260965e-01 | 0.033 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.275820e-01 | 0.033 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.275820e-01 | 0.033 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.294106e-01 | 0.032 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.303677e-01 | 0.031 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.303684e-01 | 0.031 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.307236e-01 | 0.031 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.307236e-01 | 0.031 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.307236e-01 | 0.031 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.307236e-01 | 0.031 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.333148e-01 | 0.030 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.370290e-01 | 0.028 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.370290e-01 | 0.028 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.380140e-01 | 0.028 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.427609e-01 | 0.026 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.427609e-01 | 0.026 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.427609e-01 | 0.026 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.438783e-01 | 0.025 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.439857e-01 | 0.025 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.464019e-01 | 0.024 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.479713e-01 | 0.023 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.479713e-01 | 0.023 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.479713e-01 | 0.023 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.506400e-01 | 0.022 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.533919e-01 | 0.021 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.533919e-01 | 0.021 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.533919e-01 | 0.021 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.535668e-01 | 0.021 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.565583e-01 | 0.019 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.570133e-01 | 0.019 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.570133e-01 | 0.019 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.576245e-01 | 0.019 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.583879e-01 | 0.018 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.609270e-01 | 0.017 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.609270e-01 | 0.017 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.609270e-01 | 0.017 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.609270e-01 | 0.017 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.609270e-01 | 0.017 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.631620e-01 | 0.016 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.644846e-01 | 0.016 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.644846e-01 | 0.016 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.673144e-01 | 0.014 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.677185e-01 | 0.014 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.677185e-01 | 0.014 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.694972e-01 | 0.013 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.697551e-01 | 0.013 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.706581e-01 | 0.013 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.708720e-01 | 0.013 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.716975e-01 | 0.012 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.720012e-01 | 0.012 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.723842e-01 | 0.012 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.736743e-01 | 0.012 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.742073e-01 | 0.011 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.755196e-01 | 0.011 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.779669e-01 | 0.010 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.788478e-01 | 0.009 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.788478e-01 | 0.009 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.788631e-01 | 0.009 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.799738e-01 | 0.009 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.799738e-01 | 0.009 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.803456e-01 | 0.009 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.813499e-01 | 0.008 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.816665e-01 | 0.008 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.817418e-01 | 0.008 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.817979e-01 | 0.008 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.817979e-01 | 0.008 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.828160e-01 | 0.008 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.834560e-01 | 0.007 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.846048e-01 | 0.007 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.849632e-01 | 0.007 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.854198e-01 | 0.006 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.861437e-01 | 0.006 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.863331e-01 | 0.006 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.886201e-01 | 0.005 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.886201e-01 | 0.005 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.887101e-01 | 0.005 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.887101e-01 | 0.005 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.887101e-01 | 0.005 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.895260e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.906739e-01 | 0.004 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.906739e-01 | 0.004 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.911870e-01 | 0.004 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.919665e-01 | 0.004 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.929985e-01 | 0.003 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.935805e-01 | 0.003 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.936366e-01 | 0.003 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.936536e-01 | 0.003 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.941650e-01 | 0.003 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.942167e-01 | 0.003 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.942167e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.952231e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.954688e-01 | 0.002 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.954688e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.954688e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.956866e-01 | 0.002 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.961396e-01 | 0.002 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.963997e-01 | 0.002 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.971331e-01 | 0.001 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.974996e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.981773e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.984837e-01 | 0.001 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.985046e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.988621e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.988621e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.989270e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.989659e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.990525e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.993031e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.994073e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.994177e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.994708e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.994978e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.995191e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.995554e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.995796e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.996029e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.996054e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.996054e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.996392e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.996641e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.996947e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.997293e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997450e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997540e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.997540e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998835e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998857e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999020e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999245e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999638e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999701e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999712e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999803e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999815e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999846e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999864e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999882e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999906e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999919e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999922e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999937e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999940e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999943e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999965e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999980e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999991e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999992e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999993e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999996e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |